Updated on 2024/04/25

写真a

 
YASUI Kazuya
 
Organization
Okayama University Hospital Special-Appointment Assistant Professor
Position
Special-Appointment Assistant Professor
External link

Degree

  • 学士 ( 岡山大学 )

 

Papers

  • Circulating cell-free DNA methylation patterns as non-invasive biomarkers to monitor colorectal cancer treatment efficacy without referencing primary site mutation profiles. International journal

    Kazuya Yasui, Toshiaki Toshima, Ryo Inada, Yuzo Umeda, Shuya Yano, Hiroaki Tanioka, Akihiro Nyuya, Toshiyoshi Fujiwara, Takeshi Yamada, Yoshio Naomoto, Ajay Goel, Takeshi Nagasaka

    Molecular cancer   23 ( 1 )   1 - 1   2024.1

     More details

    Language:English  

    This study investigates methylation patterns in circulating cell-free DNA (ccfDNA) for their potential role in colorectal cancer (CRC) detection and the monitoring of treatment response. Through methylation microarrays and quantitative PCR assays, we analyzed 440 samples from The Cancer Genome Atlas (TCGA) and an additional 949 CRC samples. We detected partial or extensive methylation in over 85% of cases within three biomarkers: EFEMP1, SFRP2, and UNC5C. A methylation score for at least one of the six candidate regions within these genes' promoters was present in over 95% of CRC cases, suggesting a viable detection method. In evaluating ccfDNA from 97 CRC patients and 62 control subjects, a difference in methylation and recovery signatures was observed. The combined score, integrating both methylation and recovery metrics, showed high diagnostic accuracy, evidenced by an area under the ROC curve of 0.90 (95% CI = 0.86 to 0.94). While correlating with tumor burden, this score gave early insight into disease progression in a small patient cohort. Our results suggest that DNA methylation in ccfDNA could serve as a sensitive biomarker for CRC, offering a less invasive and potentially more cost-effective approach to augment existing cancer detection and monitoring modalities, possibly supporting comprehensive genetic mutation profiling.

    DOI: 10.1186/s12943-023-01910-y

    PubMed

    researchmap

  • ASO Author Reflections: The Role of Robotic Surgery in Patients with Portal Annular Pancreas. International journal

    Kosei Takagi, Tomokazu Fuji, Kazuya Yasui, Yuzo Umeda, Toshiyoshi Fujiwara

    Annals of surgical oncology   2023.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1245/s10434-023-14778-5

    PubMed

    researchmap

  • Robotic Pancreatoduodenectomy in Portal Annular Pancreas Using a Hanging Maneuver with Indocyanine Green Fluorescence Imaging. International journal

    Kosei Takagi, Tomokazu Fuji, Motohiko Yamada, Jiro Kimura, Kazuya Yasui, Yuzo Umeda, Toshiyoshi Fujiwara

    Annals of surgical oncology   2023.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Sufficient knowledge and surgical management of portal annular pancreas (PAP) are essential for pancreatic surgery. As PAP is a relatively rare pancreatic anomaly, few studies have described surgical techniques for patients with PAP undergoing robotic pancreatoduodenectomy (RPD). PATIENTS AND METHODS: An 82-year-old female patient who underwent RPD presented with distal cholangiocarcinoma and type III PAP (the fusion of the uncinate process with the anteportal main pancreatic duct). After the Kocher maneuver and stomach transection, the pancreas was transected into the neck of the anteportal portion. The retroportal portion was dissected, encircled with hanging tape, and compressed. Blood supply from the mesenteric vessels was confirmed using indocyanine green (ICG) fluorescence imaging. Subsequently, the retroportal portion was stapled. CONCLUSIONS: This study demonstrates a unique surgical technique for type III PAP using the hanging maneuver with ICG fluorescence imaging. Surgeons should decide on the surgical strategy on the basis of the fusion and ductal anatomy of the pancreas.

    DOI: 10.1245/s10434-023-14685-9

    PubMed

    researchmap

  • ゲノム医療の最前線 循環遊離DNAメチル化パターンは原発腫瘍変異プロファイルなしに大腸癌検出とモニタリングを可能とする

    永坂 岳司, 戸嶋 俊明, 稲田 凉, 安井 和也, 楳田 祐三, 岡脇 誠, 入谷 光洋, 矢野 修也, 谷岡 洋亮, 山田 岳史, 猶本 良夫

    日本大腸肛門病学会雑誌   76 ( 9 )   A67 - A67   2023.9

     More details

    Language:English   Publisher:(一社)日本大腸肛門病学会  

    researchmap

  • Robotic Pancreaticoduodenectomy Using the Right Posterior Superior Mesenteric Artery Approach. International journal

    Kosei Takagi, Yuzo Umeda, Tomokazu Fuji, Kazuya Yasui, Toshiyoshi Fujiwara

    Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract   2023.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    DOI: 10.1007/s11605-023-05806-6

    PubMed

    researchmap

  • Innovative suture technique for robotic hepaticojejunostomy: double-layer interrupted sutures. International journal

    Kosei Takagi, Yuzo Umeda, Ryuichi Yoshida, Tomokazu Fuji, Kazuya Yasui, Takahito Yagi, Toshiyoshi Fujiwara

    Langenbeck's archives of surgery   408 ( 1 )   284 - 284   2023.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    PURPOSE: Biliary reconstruction remains a technically demanding and complicated procedure in minimally invasive hepatopancreatobiliary surgeries. No optimal hepaticojejunostomy (HJ) technique has been demonstrated to be superior for preventing biliary complications. This study aimed to investigate the feasibility of our unique technique of posterior double-layer interrupted sutures in robotic HJ. METHODS: We performed a retrospective analysis of a prospectively collected database. Forty-two patients who underwent robotic pancreatoduodenectomy using this technique between September 2020 and November 2022 at our center were reviewed. In the posterior double-layer interrupted technique, sutures were placed to bite the bile duct, posterior seromuscular layer of the jejunum, and full thickness of the jejunum. RESULTS: The median operative time was 410 (interquartile range [IQR], 388-478) min, and the median HJ time was 30 (IQR, 28-39) min. The median bile duct diameter was 7 (IQR, 6-10) mm. Of the 42 patients, one patient (2.4%) had grade B bile leakage. During the median follow-up of 12.6 months, one patient (2.4%) with bile leakage developed anastomotic stenosis. Perioperative mortality was not observed. A surgical video showing the posterior double-layer interrupted sutures in the robotic HJ is included. CONCLUSIONS: Posterior double-layer interrupted sutures in robotic HJ provided a simple and feasible method for biliary reconstruction with a low risk of biliary complications.

    DOI: 10.1007/s00423-023-03020-1

    PubMed

    researchmap

  • 【肝胆膵】切除可能膵癌に対する術前化学療法の至適戦略 血中循環腫瘍DNA内KRAS mutation profileとCA19-9値を組み合わせた膵癌予後の層別化戦略

    安井 和也, 吉田 龍一, 宮本 耕吉, 藤 智和, 高木 弘誠, 寺石 文則, 黒田 新士, 野間 和広, 楳田 祐三, 藤原 俊義

    日本消化器外科学会総会   78回   WS30 - 10   2023.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 【肝胆膵】膵頭十二指腸切除術後膵液瘻の克服を目指した工夫 膵頭十二指腸切除術のハイリスク膵空腸吻合におけるロボット支援下手術の役割

    藤 智和, 高木 弘誠, 楳田 祐三, 吉田 龍一, 安井 和也, 黒田 新士, 野間 和広, 寺石 文則, 藤原 俊儀

    日本消化器外科学会総会   78回   WS32 - 7   2023.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 非大腸癌由来の少数肝転移症例の切除適応を見極める

    岡田 尚大, 藤 智和, 楳田 祐三, 吉田 龍一, 高木 弘誠, 安井 和也, 黒田 新士, 野間 和広, 寺石 文則, 藤原 俊義

    日本消化器外科学会総会   78回   O11 - 6   2023.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 【肝胆膵】膵頭十二指腸切除術後膵液瘻の克服を目指した工夫 膵頭十二指腸切除術のハイリスク膵空腸吻合におけるロボット支援下手術の役割

    藤 智和, 高木 弘誠, 楳田 祐三, 吉田 龍一, 安井 和也, 黒田 新士, 野間 和広, 寺石 文則, 藤原 俊儀

    日本消化器外科学会総会   78回   WS32 - 7   2023.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 非大腸癌由来の少数肝転移症例の切除適応を見極める

    岡田 尚大, 藤 智和, 楳田 祐三, 吉田 龍一, 高木 弘誠, 安井 和也, 黒田 新士, 野間 和広, 寺石 文則, 藤原 俊義

    日本消化器外科学会総会   78回   O11 - 6   2023.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 【肝胆膵】切除可能膵癌に対する術前化学療法の至適戦略 血中循環腫瘍DNA内KRAS mutation profileとCA19-9値を組み合わせた膵癌予後の層別化戦略

    安井 和也, 吉田 龍一, 宮本 耕吉, 藤 智和, 高木 弘誠, 寺石 文則, 黒田 新士, 野間 和広, 楳田 祐三, 藤原 俊義

    日本消化器外科学会総会   78回   WS30 - 10   2023.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 外科専攻医の産育休後復帰支援とダイバーシティ推進のための全体教育への取り組み

    竹原 裕子, 溝尾 妙子, 小林 純子, 安井 和也, 菊池 覚次, 黒田 新士, 楳田 祐三, 吉田 龍一, 小谷 恭弘, 杉本 誠一郎, 岡崎 幹生, 枝國 忠彦, 豊岡 伸一, 笠原 真悟

    日本外科学会定期学術集会抄録集   123回   SF - 4   2023.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • Impact of educational video on performance in robotic simulation training (TAKUMI-1): a randomized controlled trial. International journal

    Kosei Takagi, Nanako Hata, Jiro Kimura, Satoru Kikuchi, Kazuhiro Noma, Kazuya Yasui, Tomokazu Fuji, Ryuichi Yoshida, Yuzo Umeda, Takahito Yagi, Toshiyoshi Fujiwara

    Journal of robotic surgery   17 ( 4 )   1547 - 1553   2023.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The use of virtual reality for simulations plays an important role in the initial training for robotic surgery. This randomized controlled trial aimed to investigate the impact of educational video on the performance of robotic simulation. Participants were randomized into the intervention (video) group that received an educational video and robotic simulation training or the control group that received only simulation training. The da Vinci® Skills Simulator was used for the basic course, including nine drills. The primary endpoint was the overall score of nine drills in cycles 1-10. Secondary endpoints included overall, efficiency, and penalty scores in each cycle, as well as the learning curves evaluated by the cumulative sum (CUSUM) analysis. Between September 2021 and May 2022, 20 participants were assigned to the video (n = 10) and control (n = 10) groups. The video group had significantly higher overall scores than the control group (90.8 vs. 72.4, P < 0.001). Significantly higher overall scores and lower penalty scores were confirmed, mainly in cycles 1-5. CUSUM analysis revealed a shorter learning curve in the video group. The present study demonstrated that educational video training can be effective in improving the performance of robotic simulation training and shortening the learning curve.

    DOI: 10.1007/s11701-023-01556-4

    PubMed

    researchmap

  • Role of the Pfannenstiel Incision in Robotic Hepato-Pancreato-Biliary Surgery. International journal

    Kosei Takagi, Yuzo Umeda, Ryuichi Yoshida, Tomokazu Fuji, Kazuya Yasui, Jiro Kimura, Nanako Hata, Takahito Yagi, Toshiyoshi Fujiwara

    Journal of clinical medicine   12 ( 5 )   2023.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Studies remain limited on the role of the Pfannenstiel incision in minimally invasive hepato-pancreato-biliary (HPB) surgery, especially robotic surgery. The role of various extraction sites in robotic HPB surgery should be understood. Herein, we describe the surgical techniques, outcomes, advantages, and disadvantages of the Pfannenstiel incision in robotic pancreatic surgery. Seventy patients underwent robotic pancreatectomy at our institution between September 2020 and October 2022. The Pfannenstiel incision was used for specimen retrieval in 55 patients. Advantages of the Pfannenstiel incision include less pain, cosmetic benefits, and a lower incidence of complications. Moreover, the specimen could be removed using the robotic system docked. However, all complex reconstructions should be performed intra-abdominally during robotic pancreatoduodenectomies. The incidence of mortality and postoperative pancreatic fistula (grade B) was 0% and 9.1%, respectively. During the median follow-up (11.2 months) after surgery, complications at the Pfannenstiel incision site included surgical site infection (n = 1, 1.8%) and incisional hernia (n = 1, 1.8%). The Pfannenstiel incision can be a useful option for specimen retrieval in minimally invasive HPB surgery, according to the surgeon's preferences and the patient's condition.

    DOI: 10.3390/jcm12051971

    PubMed

    researchmap

  • 【転移性肝癌を極める】大腸癌肝転移に対する肝切除

    楳田 祐三, 吉田 龍一, 藤 智和, 高木 弘誠, 安井 和也, 重安 邦俊, 寺石 文則, 八木 孝仁, 藤原 俊義

    消化器外科   46 ( 3 )   277 - 288   2023.3

     More details

    Language:Japanese   Publisher:(株)へるす出版  

    researchmap

  • Robotic surgery for congenital biliary dilatation using the scope switch technique (with video). International journal

    Kosei Takagi, Yuzo Umeda, Ryuichi Yoshida, Tomokazu Fuji, Kazuya Yasui, Takahito Yagi, Toshiyoshi Fujiwara

    Asian journal of surgery   2023.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    TECHNIQUE: Minimally invasive congenital biliary dilatation (CBD) surgery is technically demanding. However, few studies have reported surgical approaches of robotic surgery for CBD. This report presents robotic CBD surgery using a scope-switch technique. Our robotic surgery technique for CBD consisted of four steps: step 1, Kocher's maneuver; step 2, dissection of the hepatoduodenal ligament using the scope switch technique; step 3, preparation for the Roux-en-Y loop; and step 4, hepaticojejunostomy. RESULTS: The scope switch technique can provide different surgical approaches for dissecting the bile duct, including anterior approach by the standard position and right approach by the scope switch position. When approaching the ventral and left side of the bile duct, anterior approach with the standard position is suitable. In contrast, the lateral view by the scope switch position is preferable for approaching the bile duct laterally and dorsally. Using this technique, the dilated bile duct can be dissected circumferentially from four directions: anterior, medial, lateral, and posterior. Thereafter, complete resection of the choledochal cyst can be achieved. CONCLUSIONS: The scope switch technique in robotic surgery for CBD can be useful for dissecting around the bile duct with different surgical views, leading to the complete resection of the choledochal cyst.

    DOI: 10.1016/j.asjsur.2023.02.021

    PubMed

    researchmap

  • ADAR1 is a promising risk stratification biomarker of remnant liver recurrence after hepatic metastasectomy for colorectal cancer. International journal

    Nanako Hata, Kunitoshi Shigeyasu, Yuzo Umeda, Shuya Yano, Sho Takeda, Kazuhiro Yoshida, Tomokazu Fuji, Ryuichi Yoshida, Kazuya Yasui, Hibiki Umeda, Toshiaki Takahashi, Yoshitaka Kondo, Hiroyuki Kishimoto, Yoshiko Mori, Fuminori Teraishi, Hideki Yamamoto, Hiroyuki Michiue, Keiichiro Nakamura, Hiroshi Tazawa, Toshiyoshi Fujiwara

    Scientific reports   13 ( 1 )   2078 - 2078   2023.2

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Adenosine-to-inosine RNA editing is a process mediated by adenosine deaminases that act on the RNA (ADAR) gene family. It has been discovered recently as an epigenetic modification dysregulated in human cancers. However, the clinical significance of RNA editing in patients with liver metastasis from colorectal cancer (CRC) remains unclear. The current study aimed to systematically and comprehensively investigate the significance of adenosine deaminase acting on RNA 1 (ADAR1) expression status in 83 liver metastatic tissue samples collected from 36 patients with CRC. The ADAR1 expression level was significantly elevated in liver metastatic tissue samples obtained from patients with right-sided, synchronous, or RAS mutant-type CRC. ADAR1-high liver metastasis was significantly correlated with remnant liver recurrence after hepatic metastasectomy. A high ADAR1 expression was a predictive factor of remnant liver recurrence (area under the curve = 0.72). Results showed that the ADAR1 expression level could be a clinically relevant predictive indicator of remnant liver recurrence. Patients with liver metastases who have a high ADAR1 expression requires adjuvant chemotherapy after hepatic metastasectomy.

    DOI: 10.1038/s41598-023-29397-z

    PubMed

    researchmap

  • Surgical Techniques of Gastrojejunostomy in Robotic Pancreatoduodenectomy: Robot-Sewn versus Stapled Gastrojejunostomy Anastomosis. International journal

    Kosei Takagi, Yuzo Umeda, Ryuichi Yoshida, Tomokazu Fuji, Kazuya Yasui, Jiro Kimura, Nanako Hata, Takahito Yagi, Toshiyoshi Fujiwara

    Journal of clinical medicine   12 ( 2 )   2023.1

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Delayed gastric emptying (DGE) is a major complication of pancreatoduodenectomy (PD). Several efforts have been made to decrease the incidence of DGE. However, the optimal anastomotic method for gastro/duodenojejunostomy (GJ) remains debatable. Moreover, few studies have reported the impact of GJ surgical techniques on outcomes following robotic pancreatoduodenectomy (RPD). This study aimed to investigate the surgical outcomes of robot-sewn and stapled GJ anastomoses in RPD. METHODS: Forty patients who underwent RPD at the Okayama University Hospital between September 2020 and October 2022 were included. The outcomes between robot-sewn and stapled anastomoses were compared. RESULTS: The mean [standard deviation (SD)] operative and GJ time were 428 (63.5) and 34.0 (15.0) minutes, respectively. Postoperative outcomes included an overall incidence of DGE of 15.0%, and the mean postoperative hospital stays were 11.6 (5.3) days in length. The stapled group (n = 21) had significantly shorter GJ time than the robot-sewn group (n = 19) (22.7 min versus 46.5 min, p &lt; 0.001). Moreover, stapled GJ cases were significantly associated with a lower incidence of DGE (0% versus 21%, p = 0.01). Although not significant, the stapled group tended to have shorter postoperative hospital stays (9.9 days versus 13.5 days, p = 0.08). CONCLUSIONS: Our findings suggest that stapled GJ anastomosis might decrease anastomotic GJ time and incidence of DGE after RPD. Surgeons should select a suitable method for GJ anastomosis based on their experiences with RPD.

    DOI: 10.3390/jcm12020732

    PubMed

    researchmap

  • Role of Surgery for Pancreatic Ductal Adenocarcinoma in the Era of Multidisciplinary Treatment. International journal

    Kosei Takagi, Yuzo Umeda, Ryuichi Yoshida, Tomokazu Fuji, Kazuya Yasui, Takahito Yagi, Toshiyoshi Fujiwara

    Journal of clinical medicine   12 ( 2 )   2023.1

     More details

    Language:English  

    The incidence and mortality rates of pancreatic ductal adenocarcinoma (PDAC) have increased in recent years worldwide [...].

    DOI: 10.3390/jcm12020465

    PubMed

    researchmap

  • Impact of cancer-associated fibroblasts on survival of patients with ampullary carcinoma. International journal

    Kosei Takagi, Kazuhiro Noma, Yasuo Nagai, Satoru Kikuchi, Yuzo Umeda, Ryuichi Yoshida, Tomokazu Fuji, Kazuya Yasui, Takehiro Tanaka, Hajime Kashima, Takahito Yagi, Toshiyoshi Fujiwara

    Frontiers in oncology   13   1072106 - 1072106   2023

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Cancer-associated fibroblasts (CAFs) reportedly enhance the progression of gastrointestinal surgery; however, the role of CAFs in ampullary carcinomas remains poorly examined. This study aimed to investigate the effect of CAFs on the survival of patients with ampullary carcinoma. MATERIALS AND METHODS: A retrospective analysis of 67 patients who underwent pancreatoduodenectomy between January 2000 and December 2021 was performed. CAFs were defined as spindle-shaped cells that expressed α-smooth muscle actin (α-SMA) and fibroblast activation protein (FAP). The impact of CAFs on survival, including recurrence-free (RFS) and disease-specific survival (DSS), as well as prognostic factors associated with survival, was analyzed. RESULTS: The high-α-SMA group had significantly worse 5-year RFS (47.6% vs. 82.2%, p = 0.003) and 5-year DSS (67.5% vs. 93.3%, p = 0.01) than the low-α-SMA group. RFS (p = 0.04) and DSS (p = 0.02) in the high-FAP group were significantly worse than those in the low-FAP group. Multivariable analyses found that high α-SMA expression was an independent predictor of RFS [hazard ratio (HR): 3.68; 95% confidence intervals (CI): 1.21-12.4; p = 0.02] and DSS (HR: 8.54; 95% CI: 1.21-170; p = 0.03). CONCLUSIONS: CAFs, particularly α-SMA, can be useful predictors of survival in patients undergoing radical resection for ampullary carcinomas.

    DOI: 10.3389/fonc.2023.1072106

    PubMed

    researchmap

  • 早期栄養介入とNSTによる多職種連携により良好な転帰を得た多発褥瘡患者の1例

    開原 裕子, 深川 真里, 片山 祥子, 長谷川 祐子, 高橋 絢子, 大木 晴美, 山重 達也, 川西 英明, 三浦 太郎, 金 聖暎, 山田 太平, 安井 和也, 菊地 覚次, 田辺 俊介, 四方 賢一

    学会誌JSPEN   4 ( Suppl.2 )   160 - 161   2022.12

     More details

    Language:Japanese   Publisher:(一社)日本臨床栄養代謝学会  

    researchmap

  • 切除可能膵癌における血中循環腫瘍DNA内Kras遺伝子変異とCA19-9値による予後層別化の試み

    宮本 耕吉, 吉田 龍一, 重安 邦俊, 安井 和也, 高木 弘誠, 藤 智和, 楳田 祐三, 八木 孝仁, 藤原 俊義

    日本分子腫瘍マーカー研究会誌   38   20 - 21   2022.12

     More details

    Language:Japanese   Publisher:日本分子腫瘍マーカー研究会  

    researchmap

  • Surgical Strategies to Dissect around the Superior Mesenteric Artery in Robotic Pancreatoduodenectomy. International journal

    Kosei Takagi, Yuzo Umeda, Ryuichi Yoshida, Tomokazu Fuji, Kazuya Yasui, Jiro Kimura, Nanako Hata, Kento Mishima, Takahito Yagi, Toshiyoshi Fujiwara

    Journal of clinical medicine   11 ( 23 )   2022.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The concept of the superior mesenteric artery (SMA)-first approach has been widely accepted in pancreatoduodenectomy. However, few studies have reported surgical approaches to the SMA in robotic pancreatoduodenectomy (RPD). Herein, we present our surgical strategies to dissect around the SMA in RPD. Among the various approaches, our standard protocol for RPD included the right approach to the SMA, which can result in complete tumor resection in most cases. In patients with malignant diseases requiring lymphadenectomy around the SMA, we developed a novel approach by combining the left and right approaches in RPD. Using this approach, circumferential dissection around the SMA can be achieved through both the left and right sides. This approach can also be helpful in patients with obesity or intra-abdominal adhesions. The present study summarizes the advantages and disadvantages of both the approaches during RPD. To perform RPD safely, surgeons should understand the different surgical approaches and select the best approach or a combination of different approaches, depending on demographic, anatomical, and oncological factors.

    DOI: 10.3390/jcm11237112

    PubMed

    researchmap

  • Neonatal hemochromatosis with εγδβ-thalassemia: a case report and analysis of serum iron regulators. International journal

    Mitsuru Tsuge, Aya Kodera, Hiromi Sumitomo, Tooru Araki, Ryuichi Yoshida, Kazuya Yasui, Hiroki Sato, Yosuke Washio, Kana Washio, Kenji Shigehara, Masato Yashiro, Takahito Yagi, Hirokazu Tsukahara

    BMC pediatrics   22 ( 1 )   622 - 622   2022.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Neonatal hemochromatosis causes acute liver failure during the neonatal period, mostly due to gestational alloimmune liver disease (GALD). Thalassemia causes hemolytic anemia and ineffective erythropoiesis due to mutations in the globin gene. Although neonatal hemochromatosis and thalassemia have completely different causes, the coexistence of these diseases can synergistically exacerbate iron overload. We report that a newborn with εγδβ-thalassemia developed neonatal hemochromatosis, which did not respond to iron chelators and rapidly worsened, requiring living-donor liver transplantation. CASE PRESENTATION: A 1-day-old Japanese boy with hemolytic anemia and targeted red blood cells was diagnosed with εγδβ-thalassemia by genetic testing, and required frequent red blood cell transfusions. At 2 months after birth, exacerbation of jaundice, grayish-white stool, and high serum ferritin levels were observed, and liver biopsy showed iron deposition in hepatocytes and Kupffer cells. Magnetic resonance imaging scans showed findings suggestive of iron deposits in the liver, spleen, pancreas, and bone marrow. The total amount of red blood cell transfusions administered did not meet the criteria for post-transfusion iron overload. Administration of an iron-chelating agent was initiated, but iron overload rapidly progressed to liver failure without improvement in jaundice and liver damage. He underwent living-donor liver transplantation from his mother, after which iron overload disappeared, and no recurrence of iron overload was observed. Immunohistochemical staining for C5b-9 in the liver was positive. Serum hepcidin levels were low and serum growth differentiation factor-15 levels were high prior to living-donor liver transplantation. CONCLUSIONS: We reported that an infant with εγδβ-thalassemia developed NH due to GALD, and that coexistence of ineffective erythropoiesis in addition to erythrocyte transfusions may have exacerbated iron overload. Low serum hepcidin levels, in this case, might have been caused by decreased hepcidin production arising from fetal liver damage due to neonatal hemochromatosis and increased hepcidin-inhibiting hematopoietic mediators due to the ineffective hematopoiesis observed in thalassemia.

    DOI: 10.1186/s12887-022-03706-3

    PubMed

    researchmap

  • Genomically stable gastric cancer characterized by hypomethylation in Wnt signal cascade. International journal

    Hiroaki Tanioka, Yoshiko Mori, Takehiro Tanaka, Kazuya Yasui, Keisuke Kimura, Yuzo Umeda, Toshiyoshi Fujiwara, Akihiro Nyuya, Shuya Yano, Takeshi Nagasaka, Takeshi Nagasaka

    Oncology   101 ( 2 )   105 - 116   2022.10

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Introduction Gastric cancer is divided into four subtypes by their molecular features linked with genetic alterations, e.g., Epstein-Barr virus (EBV), microsatellite instability-high (MSI-high), chromosomal instability (CIN), and genomically stable (GS), called as TCGA classification. In this study, we tried to clarify the epigenetic features of the four GC subtypes according to aberrant methylation status in 23 loci. Methods A total of 98 gastric cancers and their normal gastric mucosa samples were included in this study. We divided gastric cancers into TCGA subtypes which were determined in line with MSI-high, EBV, CIN, to GS by their molecular features. The 13 loci of polymorphic microsatellite sequences were used to determine loss of heterogeneity (LOH) for the detection of CIN. The MSI status was determined by three mononucleotide repeat markers. Infection of EBV was determined by recovering EBV BNRF1 sequence from genomic DNA collected from gastric cancers. Methylation status of 23 loci was investigated by the combined bisulfite restriction analysis (COBRA). Status of other findings, e.g., KRAS mutations, HER2 expression status and infection of helicobacter pylori were confirmed. Results Gastric cancers were divided into MSI (13%), EBV (7%), CIN (53%), and GS (27%). By histological classification, poorly differentiated adenocarcinoma (por) was more in tumors categorized in MSI-high, and GS and signet-ring cell carcinoma (sig) was more in GS. Among the 23 loci investigated their methylation status, 18 loci were significantly hypermethylated in caner tissues. A unsupervised clustering divided gastric cancers into two clusters, and revealed that most GS tumors clustered together in a cluster that exhibited lower methylation levels, distinct from the other subtypes. The inter-variable clustering revealed that a cluster contained the three loci (SFRP2-region 1/2 and APC) belonging to the Wnt signal cascade (Wnt-associated loci). The mean methylation score of Wnt-associated loci was the lowest in GS tumors (MSI-high: 2.7 [95% confidence interval (CI), 2.3-2.9]; EBV:2.1[1.2-3.1]; CIN: 2.4 [2.2-2.7]; GS: 1.3 [0.8-0.7]). In contrast, the mean methylation score of the other 15 loci was significantly higher in MSI-high, while that in GS was as same as that in EBV or CIN (MSI- high: 10.4 [8.3-12.4]; EBV:5.7 [1.7-9.7]; CIN: 4.4 [3.6-5.1]; GS: 3.4 [2.2-4.6]). Additionally, the lower methylation score of Wnt-associated loci was observed only in sig tumors. Conclusions GS subtype tumors have the potential to possess distinct signatures in DNA hypomethylation profiles in Wnt signaling pathway, especially in signet-ring cell carcinoma.

    DOI: 10.1159/000527098

    PubMed

    researchmap

  • Current status and future perspectives of minimally invasive and open radical antegrade modular pancreatosplenectomy for pancreatic ductal adenocarcinoma: a review

    Kosei Takagi, Yuzo Umeda, Ryuichi Yoshida, Tomokazu Fuji, Kazuya Yasui, Takahito Yagi, Toshiyoshi Fujiwara

    Laparoscopic Surgery   6   39 - 39   2022.10

     More details

    Publishing type:Research paper (scientific journal)   Publisher:AME Publishing Company  

    DOI: 10.21037/ls-22-39

    researchmap

  • Wnt signaling cascadeにおける低メチル化を特徴とするGenomically stable胃癌

    谷岡 洋亮, 安井 和也, 母里 淑子, 田中 健大, 木村 圭介, 入谷 光洋, 岡脇 誠, 矢野 修也, 山口 佳之, 永坂 岳司

    日本癌治療学会学術集会抄録集   60回   P75 - 1   2022.10

     More details

    Language:English   Publisher:(一社)日本癌治療学会  

    researchmap

  • 膵がんの治療成績は向上したか? 切除可能膵癌に対するNAC-GS療法は予後を改善したか? 非切除例を含む全コホート解析

    安井 和也, 吉田 龍一, 楳田 祐三, 藤 智和, 高木 弘誠, 宮本 耕吉, 黒田 新士, 野間 和広, 八木 孝仁, 藤原 俊義

    日本癌治療学会学術集会抄録集   60回   OWS15 - 5   2022.10

     More details

    Language:English   Publisher:(一社)日本癌治療学会  

    researchmap

  • Robotic Spleen-Preserving Distal Pancreatectomy with Preservation of Splenic Vessels Using the Gastrohepatic Ligament Approach: The Superior Window Approach in the Kimura Technique. International journal

    Kosei Takagi, Ryuichi Yoshida, Yuzo Umeda, Tomokazu Fuji, Kazuya Yasui, Takahito Yagi, Toshiyoshi Fujiwara

    Digestive surgery   39 ( 4 )   137 - 140   2022.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Minimally invasive spleen-preserving distal pancreatectomy (SPDP) is technically challenging, and only a few reports have described surgical approaches for minimally invasive SPDP. This report demonstrates our novel gastrohepatic ligament approach in robotic SPDP with preservation of the splenic vessels (the superior window approach in the Kimura technique). Our gastrohepatic ligament approach for robotic SPDP included four steps. First, the gastrohepatic ligament was divided extensively, and the pancreas was confirmed (step 1). In this step, we did not lift the stomach, nor did we divide the gastrocolic ligament. Next, the superior and inferior borders of the pancreas were dissected, and tunneling of the pancreas on the superior mesenteric vein was performed (step 2). Following the division of the pancreas (step 3), the pancreatic body and tail were dissected from the medial to the lateral side with preservation of the splenic vessels (step 4). Using this approach, the pancreas can be directly accessed via the gastrohepatic ligament route and dissected without division of the gastrocolic ligament or retraction of the stomach. The present approach for robotic SPDP preserves splenic vessels, facilitating easy access to the pancreas with minimal dissection, and may be optional in selected patients, including those with low body mass index.

    DOI: 10.1159/000527249

    PubMed

    researchmap

  • Surgical Strategies to Approaching the Splenic Artery in Robotic Distal Pancreatectomy. International journal

    Kosei Takagi, Kenjiro Kumano, Yuzo Umeda, Ryuichi Yoshida, Tomokazu Fuji, Kazuya Yasui, Takahito Yagi, Toshiyoshi Fujiwara

    Anticancer research   42 ( 9 )   4471 - 4476   2022.9

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND/AIM: Understanding different surgical approaches and anatomical landmarks adjacent to the splenic artery (SpA) is important for safe robotic distal pancreatectomy (RDP). Herein, we propose our standardized RDP techniques, focusing on these issues. PATIENTS AND METHODS: Between April 2021 and April 2022, 19 patients who underwent RDP at our Institution were reviewed. Anatomical patterns of the SpA were classified into three types: Type 1, no pancreatic parenchyma on the root of the SpA; type 2, any pancreatic parenchyma on the root of the SpA; and type 3, dorsal pancreatic artery around the bifurcation of the common hepatic artery and SpA. Next, the surgical strategy for approaching the SPA was determined according to the location of the pancreatic transection line: On the superior mesenteric vein (SMV) or on the left side of the root of the SpA. RESULTS: There were seven cases of type 1, nine cases of type 2, and three cases of type 3. When transecting the pancreas on the SMV, the SpA-first ligation technique was used for type 1 SpA anatomy, and the pancreas-first division technique was applied for types 2 and 3. In patients in whom the pancreas was transected at the left side of the root of the SpA, the SpA-first ligation technique was used. CONCLUSION: Our standardized surgical strategy based on anatomical landmarks and focusing on the approach to the SpA in RDP is demonstrated. Our strategy should help trainees approach the SpA and perform RDP safely.

    DOI: 10.21873/anticanres.15947

    PubMed

    researchmap

  • 男女を問わず外科医が輝き続けるために ステレオタイプ・スレットという問題とニュースレターの果たす役割

    竹原 裕子, 溝尾 妙子, 小林 純子, 坂本 美咲, 新田 薫, 工藤 由里絵, 安井 和也, 菊池 覚次, 黒田 新士, 吉田 龍一, 岡崎 幹生, 枝園 忠彦, 山根 正修, 小谷 恭弘, 豊岡 伸一, 笠原 真悟, 土井原 博義, 藤原 俊義

    日本外科学会雑誌   123 ( 5 )   501 - 502   2022.9

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 切除可能膵癌における血中循環腫瘍DNA内Kras遺伝子変異とCA19-9値による予後層別化の試み

    宮本 耕吉, 吉田 龍一, 重安 邦俊, 安井 和也, 高木 弘誠, 藤 智和, 楳田 祐三, 八木 孝二, 藤原 俊義

    日本分子腫瘍マーカー研究会プログラム・講演抄録   42回   78 - 79   2022.9

     More details

    Language:Japanese   Publisher:日本分子腫瘍マーカー研究会  

    researchmap

  • 男女を問わず外科医が輝き続けるために ステレオタイプ・スレットという問題とニュースレターの果たす役割

    竹原 裕子, 溝尾 妙子, 小林 純子, 坂本 美咲, 新田 薫, 工藤 由里絵, 安井 和也, 菊池 覚次, 黒田 新士, 吉田 龍一, 岡崎 幹生, 枝園 忠彦, 山根 正修, 小谷 恭弘, 豊岡 伸一, 笠原 真悟, 土井原 博義, 藤原 俊義

    日本外科学会雑誌   123 ( 5 )   501 - 502   2022.9

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 切除可能膵癌における血中循環腫瘍DNA内Kras遺伝子変異とCA19-9値による予後層別化の試み

    宮本 耕吉, 吉田 龍一, 重安 邦俊, 安井 和也, 高木 弘誠, 藤 智和, 楳田 祐三, 八木 孝二, 藤原 俊義

    日本分子腫瘍マーカー研究会プログラム・講演抄録   42回   78 - 79   2022.9

     More details

    Language:Japanese   Publisher:日本分子腫瘍マーカー研究会  

    researchmap

  • RNA editing facilitates the enhanced production of neoantigens during the simultaneous administration of oxaliplatin and radiotherapy in colorectal cancer. International journal

    Yasuhiro Komatsu, Kunitoshi Shigeyasu, Shuya Yano, Sho Takeda, Kazutaka Takahashi, Nanako Hata, Hibiki Umeda, Kazuhiro Yoshida, Yoshiko Mori, Kazuya Yasui, Ryuichi Yoshida, Yoshitaka Kondo, Hiroyuki Kishimoto, Fuminori Teraishi, Yuzo Umeda, Shunsuke Kagawa, Hiroyuki Michiue, Hiroshi Tazawa, Ajay Goel, Toshiyoshi Fujiwara

    Scientific reports   12 ( 1 )   13540 - 13540   2022.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Most cases of colorectal cancers (CRCs) are microsatellite stable (MSS), which frequently demonstrate lower response rates to immune checkpoint inhibitors (ICIs). RNA editing produces neoantigens by altering amino acid sequences. In this study, RNA editing was induced artificially by chemoradiation therapy (CRT) to generate neoantigens in MSS CRCs. Altogether, 543 CRC specimens were systematically analyzed, and the expression pattern of ADAR1 was investigated. In vitro and in vivo experiments were also performed. The RNA editing enzyme ADAR1 was upregulated in microsatellite instability-high CRCs, leading to their high affinity for ICIs. Although ADAR1 expression was low in MSS CRC, CRT including oxaliplatin (OX) treatment upregulated RNA editing levels by inducing ADAR1. Immunohistochemistry analyses showed the upregulation of ADAR1 in patients with CRC treated with CAPOX (capecitabine + OX) radiation therapy relative to ADAR1 expression in patients with CRC treated only by surgery (p < 0.001). Compared with other regimens, CRT with OX effectively induced RNA editing in MSS CRC cell lines (HT29 and Caco2, p < 0.001) via the induction of type 1 interferon-triggered ADAR1 expression. CRT with OX promoted the RNA editing of cyclin I, a neoantigen candidate. Neoantigens can be artificially induced by RNA editing via an OX-CRT regimen. CRT can promote proteomic diversity via RNA editing.

    DOI: 10.1038/s41598-022-17773-0

    PubMed

    researchmap

  • 【肝胆膵】大腸癌肝転移におけるBRとURの定義 BR大腸癌肝転移に対する肝切除アプローチ Vessel-Skeletonized Parenchyma-sparing Hepatectomyの有用性

    楳田 祐三, 藤 智和, 高木 弘誠, 安井 和也, 黒田 新士, 吉田 龍一, 野間 和広, 寺石 文則, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   77回   PD1 - 10   2022.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 術前化学療法を施行した膵癌患者における代謝栄養学的指標の意義に関する検討

    佐藤 博紀, 吉田 龍一, 安井 和也, 楳田 祐三, 藤 智和, 高木 弘誠, 黒田 新士, 野間 和広, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   77回   P224 - 3   2022.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • Favorable control of hepatocellular carcinoma with peritoneal dissemination by surgical resection using indocyanine green fluorescence imaging: a case report and review of the literature. International journal

    Yuma Tani, Hiroki Sato, Ryuichi Yoshida, Kazuya Yasui, Yuzo Umeda, Kazuhiro Yoshida, Tomokazu Fuji, Kenjiro Kumano, Kosei Takagi, Masaaki Kagoura, Takahito Yagi, Toshiyoshi Fujiwara

    Journal of medical case reports   16 ( 1 )   222 - 222   2022.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: The optimal management for peritoneal dissemination in patients with hepatocellular carcinoma remains unclear. Although several reports have described the usefulness of surgical resection, the indications should be carefully considered. Herein, we report the case of a patient with hepatocellular carcinoma with peritoneal recurrence who underwent surgical resection using an indocyanine green fluorescence navigation system and achieved favorable disease control. CASE PRESENTATION: A 45-year-old Asian woman underwent left hemihepatectomy for a ruptured hepatocellular carcinoma. Seventeen months after the initial surgery, a single nodule near the cut surface of the liver was detected on computed tomography, along with elevation of tumor markers. The patient was diagnosed with peritoneal metastasis and underwent a surgical resection. Twelve months later, a single nodule on the dorsal side of the right hepatic lobe was detected on computed tomography, and we performed surgical resection. Indocyanine green (0.5 mg/kg) was intravenously administered 3 days before surgery, and the indocyanine green fluorescence imaging system revealed clear green fluorescence in the tumor, which helped us perform complete resection. Indocyanine green fluorescence enabled the detection of additional lesions that could not be identified by preoperative imaging, especially in the second metastasectomy. There was no further recurrence at 3 months postoperatively. CONCLUSION: When considering surgical intervention for peritoneal recurrence in patients with hepatocellular carcinoma, complete resection is mandatory. Given that disseminated nodules are sometimes too small to be detected by preoperative imaging studies, intraoperative indocyanine green fluorescence may be an essential tool for determining the indications for surgical resection.

    DOI: 10.1186/s13256-022-03440-5

    PubMed

    researchmap

  • Adenomatoid mesothelioma arising from the diaphragm: a case report and review of the literature. International journal

    Kenta Kawabe, Hiroki Sato, Akiko Kitano, Ryuichi Yoshida, Kazuya Yasui, Yuzo Umeda, Kazuhiro Yoshida, Tomokazu Fuji, Kenjiro Kumano, Kosei Takagi, Masaaki Kagoura, Takahito Yagi, Toshiyoshi Fujiwara

    Journal of medical case reports   16 ( 1 )   228 - 228   2022.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Adenomatoid mesothelioma is a rare subtype of malignant mesothelioma that can be confused with adenomatoid tumors, which are classified as benign. The clinical features and optimal management of adenomatoid mesothelioma have not been elucidated in the literature. In this report, we present an extremely rare case of adenomatoid mesothelioma that developed on the peritoneal surface of the diaphragm as well as a literature review of adenomatoid mesothelioma in the abdominal cavity. CASE PRESENTATION: The patient was a 61-year-old Japanese woman who had undergone resection of a malignant peripheral nerve sheath tumor of the hand 18 years prior. She was diagnosed with clinical stage I lung adenocarcinoma on follow-up chest radiography. Simultaneously, a 20-mm enhancing nodule with slow growth on the right diaphragm was detected on contrast-enhanced computed tomography. She presented no specific clinical symptoms. At this point, the lesion was suspected to be a hypervascular tumor of borderline malignancy, such as a solitary fibrous tumor. After a left upper lobectomy for lung adenocarcinoma, she was referred to our department, and laparoscopic tumor resection was performed. Adenomatoid tumors were also considered based on the histopathological and immunohistochemical analyses, but we made the final diagnosis of adenomatoid mesothelioma using the results of the genetic profile. The patient remains alive, with no recurrence noted 6 months after surgery. CONCLUSION: We encountered a valuable case of adenomatoid mesothelioma of peritoneal origin. There are some previously reported cases of adenomatoid mesothelioma and adenomatoid tumors that may need to be recategorized according to the current classification. It is important to accumulate and share new findings to clarify the clinicopathological characteristics and genetic status of adenomatoid mesothelioma.

    DOI: 10.1186/s13256-022-03420-9

    PubMed

    researchmap

  • Optimal surveillance of intraductal papillary mucinous neoplasms of the pancreas focusing on remnant pancreas recurrence after surgical resection. International journal

    Tomokazu Fuji, Yuzo Umeda, Kosei Takagi, Ryuichi Yoshida, Kazuhiro Yoshida, Kazuya Yasui, Kazuyuki Matsumoto, Hironari Kato, Takahito Yagi, Toshiyoshi Fujiwara

    BMC cancer   22 ( 1 )   588 - 588   2022.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: The international consensus guidelines for intraductal papillary mucinous neoplasm of the pancreas (IPMN) presented clinical features as indications for surgery. Whereas surveillance for recurrence, including de novo lesions, is essential, optimal surveillance protocols have not been established. AIM AND METHODS: This study aimed to assess the clinical features of recurrence at the remnant pancreas (Rem-Panc) and extra-pancreas (Ex-Panc) after surgery for IPMN. Ninety-one patients of IPMN that underwent detailed preoperative assessment and pancreatectomy were retrospectively analyzed, focusing especially on the type of recurrence. RESULTS: The IPMNs were finally diagnosed as low-grade dysplasia (LDA, n = 42), high-grade dysplasia (HAD, n = 19), and invasive carcinoma (IPMC, n = 30). Recurrence was observed in 26 patients (29%), of which recurrence was seen at Rem-Panc in 19 patients (21%) and Ex-Panc in 7 patients (8%). The frequency of Rem-Panc recurrence was 10% in LDA, 21% in HDA, and 37% in IPMC. On the other hand, Ex-Panc recurrence was observed only in IPMC (23%). Ex-Panc recurrence showed shorter median recurrence-free survival (RFS) and overall survival (OS) than Rem-Panc recurrence (median RFS 8 months vs. 35 months, p < 0.001; median OS 25 months vs. 72 months, p < 0.001). Regarding treatment for Rem-Panc recurrence, repeat pancreatectomy resulted in better OS than no repeat pancreatectomy (MST 36 months vs. 15.5 months, p = 0.033). On multivariate analysis, main duct stenosis or disruption as a preoperative feature (hazard ratio [HR] 10.6, p = 0.002) and positive surgical margin (HR 4.4, p = 0.018) were identified as risk factors for Rem-Panc recurrence. CONCLUSIONS: The risk factors for Rem-Panc and Ex-Panc recurrence differ. Therefore, optimal surveillance on these features is desirable to ensure that repeat pancreatectomy for Rem-Panc recurrence can be an appropriate surgical intervention.

    DOI: 10.1186/s12885-022-09650-w

    PubMed

    researchmap

  • Feasibility of local therapy for recurrent pancreatic cancer. International journal

    Hiroki Sato, Ryuichi Yoshida, Kazuya Yasui, Yuzo Umeda, Kazuhiro Yoshida, Tomokazu Fuji, Kenjiro Kumano, Kosei Takagi, Takahito Yagi, Toshiyoshi Fujiwara

    Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.]   22 ( 6 )   774 - 781   2022.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Despite advances in perioperative management, recurrence after curative pancreatectomy is a critical issue in the treatment of pancreatic ductal adenocarcinoma (PDAC). The significance of local therapy for recurrent PDAC remains unclear. METHODS: We reviewed the medical records of patients with PDAC who underwent curative resection at our institution between January 2009 and December 2019. We examined the patterns of relapse and assessed the clinical outcomes of patients with recurrence who underwent local therapy, including surgical resection, radiotherapy, and radiofrequency ablation. RESULTS: A total of 246 patients with PDAC who underwent R0 or R1 resection were included in this study. The 3-year overall survival (OS) rate was 39.8%, and the 1-year recurrence-free survival rate was 51.2% for the entire population. Recurrence was observed in 172/246 (69.9%) patients, including multiple site recurrences in 50, liver metastasis in 41, locoregional recurrence in 34, and peritoneal dissemination in 27. Of the 172 patients, treatment was administered in 137 (79.7%), and 16 received local therapy, including surgical resection (n = 13), radiotherapy (n = 5), and RFA (n = 1). PS-matched analysis revealed that patients with recurrence who were treated with chemotherapy combined with local therapy showed better post-recurrence survival rates than those treated with chemotherapy alone (P = 0.016). Detailed clinical courses of these patients are presented in the main manuscript. CONCLUSIONS: Our results suggest that a multimodal approach may improve the clinical outcomes of patients with recurrent PDAC.

    DOI: 10.1016/j.pan.2022.05.004

    PubMed

    researchmap

  • Regulatory T cells induce a suppressive immune milieu and promote lymph node metastasis in intrahepatic cholangiocarcinoma. International journal

    Daisuke Konishi, Yuzo Umeda, Kazuhiro Yoshida, Kunitoshi Shigeyasu, Shuya Yano, Tomohiro Toji, Sho Takeda, Ryuichi Yoshida, Kazuya Yasui, Tomokazu Fuji, Kazuyuki Matsumoto, Hiroyuki Kishimoto, Hiroyuki Michiue, Fuminori Teraishi, Hironari Kato, Hiroshi Tazawa, Hiroyuki Yanai, Takahito Yagi, Ajay Goel, Toshiyoshi Fujiwara

    British journal of cancer   127 ( 4 )   757 - 765   2022.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Emerging evidence indicates that immunogenicity plays an important role in intrahepatic cholangiocarcinoma (ICC). Herein, we systematically evaluated the clinical relevance of immunogenicity in ICC. METHODS: Highly immunogenic ICCs identified in the public dataset and the Cancer Immunome Atlas (TCIA) were assessed to determine the prognostic impact of immunogenicity in ICC and key components after curative resection. We also investigated the clinical relevance of the immune milieu in ICC. RESULTS: Using the Gene Expression Omnibus dataset 89749 and TCIA, we identified CD8+/forkhead box P3 (FoxP3)+ tumour-infiltrating lymphocytes (TILs), T-cell immunoglobulin and mucin domain 3 (TIM-3) and human leukocyte antigen-A (HLA-A) in highly immunogenic ICCs. Immunohistochemical analysis of the in-house cohort showed that intratumoral FoxP3+ TILs correlated with CD8+ TILs (P = 0.045, Fisher's exact test) and that high FoxP3+/CD8+ ratio (FCR) was an important marker for poor survival (P < 0.001, log-rank test). Furthermore, the FCR was higher in tumour-free lymph nodes in ICCs with lymph node metastases than in those without lymph node metastases (P = 0.003, Mann-Whitney U test). CONCLUSIONS: FCR should be considered an important biomarker that represents the immune environment of ICC based on its potentially important role in tumour progression, especially lymph node metastasis.

    DOI: 10.1038/s41416-022-01838-y

    PubMed

    researchmap

  • Prognostic Value of the Regional Lymph Node Station in Pancreatic Neuroendocrine Tumor. International journal

    Kosei Takagi, Yuzo Umeda, Ryuichi Yoshida, Kazuhiro Yoshida, Tomokazu Fuji, Kenjiro Kumano, Kazuya Yasui, Takahito Yagi, Toshiyoshi Fujiwara

    Anticancer research   42 ( 5 )   2797 - 2801   2022.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND/AIM: Little is known regarding the impact of lymph node dissection on survival benefit after curative resection for pancreatic neuroendocrine tumor (PNET). This study aimed to evaluate the efficacy of lymph node dissection based on tumor location of PNET. PATIENTS AND METHODS: A retrospective study, including 50 patients with surgical resection for PNET between 2004 and 2020, was performed. The efficacy index (EI) was calculated by multiplication of the incidence of lymph node metastasis (LNM) at the station and the 5-year survival rate of patients with LNM at the station. RESULTS: In the pancreatic head tumors, the peri-pancreatic head and superior mesenteric artery lymph node stations had high EI of 13.3 and 25, respectively. In contrast, other stations, including stations 8 and 12, had zero EI. In the pancreatic body and tail tumors, only the splenic artery lymph node station had a survival benefit from lymph node dissection with an EI of 6.7. CONCLUSION: The extent of lymph node dissection for PNET should be decided based on the efficacy of lymph node dissection in accordance with tumor location. Our findings may be helpful in determining the extent of lymph node dissection required.

    DOI: 10.21873/anticanres.15760

    PubMed

    researchmap

  • ステレオタイプ・スレットという問題とニュースレターの果たす役割

    竹原 裕子, 溝尾 妙子, 小林 純子, 坂本 美咲, 新田 薫, 工藤 由里絵, 安井 和也, 菊池 覚次, 黒田 新士, 吉田 龍一, 岡崎 幹生, 杉本 誠一郎, 枝園 忠彦, 小谷 恭弘, 豊岡 伸一, 笠原 真悟, 藤原 俊義, 土井原 博義

    日本外科学会定期学術集会抄録集   122回   SP - 6   2022.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • ステレオタイプ・スレットという問題とニュースレターの果たす役割

    竹原 裕子, 溝尾 妙子, 小林 純子, 坂本 美咲, 新田 薫, 工藤 由里絵, 安井 和也, 菊池 覚次, 黒田 新士, 吉田 龍一, 岡崎 幹生, 杉本 誠一郎, 枝園 忠彦, 小谷 恭弘, 豊岡 伸一, 笠原 真悟, 藤原 俊義, 土井原 博義

    日本外科学会定期学術集会抄録集   122回   SP - 6   2022.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • Surgical resection of mixed neuroendocrine-non-neuroendocrine neoplasm in the biliary system: a report of two cases. International journal

    Ayano Tamaki, Yuma Tani, Hiroki Sato, Ryuichi Yoshida, Kazuya Yasui, Shigeru Horiguchi, Takashi Kuise, Yuzo Umeda, Kazuhiro Yoshida, Tomokazu Fuji, Kenjiro Kumano, Kosei Takagi, Takahito Yagi, Toshiyoshi Fujiwara

    Surgical case reports   8 ( 1 )   38 - 38   2022.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Mixed neuroendocrine-non-neuroendocrine neoplasm (MINEN) is a rare disease and there is scarce literature on its diagnosis, treatment, and prognosis. We encountered two unusual cases of MINEN in the biliary tract, one in the ampulla of Vater and the other in the distal bile duct. In this report, we describe the clinical course of these two cases in detail. CASE PRESENTATION: Case 1: A 69-year-old woman presented with a chief complaint of epigastric pain. When endoscopic sphincterotomy and retrograde biliary drainage were performed for gallstone pancreatitis, an ulcerated lesion was found in the ampulla of the Vater. Based on the biopsy results, the lesion was diagnosed as the ampulla of Vater carcinoma and subtotal stomach-preserving pancreatoduodenectomy (SSPPD) was performed. Postoperative histopathological examination revealed the coexistence of adenocarcinoma and neuroendocrine carcinoma components, consistent with the diagnosis of MINEN. In addition, lymph node metastasis was found on the dorsal side of the pancreas and the metastatic component was adenocarcinoma. Adjuvant chemotherapy with etoposide and cisplatin was administered for 6 months, and presently the patient is alive without recurrence 64 months after surgery. Case 2: A 79-year-old man presented with a chief complaint of anorexia. Cholangiography showed severe stenosis of the distal bile duct. A biopsy was conducted from the stenotic lesion and it revealed the lesion to be adenocarcinoma. A diagnosis of distal bile duct carcinoma was made, and SSPPD was performed. Histopathological examination revealed the coexistence of adenocarcinoma and neuroendocrine carcinoma components, and the tumor was confirmed as MINEN of the distal bile duct. No adjuvant chemotherapy was administered due to the poor performance status. 7 months later, the patient was found to have a liver metastasis. CONCLUSION: We experienced two valuable cases of biliary MINEN. To identify better treatments, it is important to consider the diversity of individual cases and to continue sharing a variety of cases with different presentations.

    DOI: 10.1186/s40792-022-01386-w

    PubMed

    researchmap

  • 移植I 葛西術後減黄不良患児に対する肝移植時期の検討

    藤 智和, 金平 典行, 佐藤 博紀, 高木 弘誠, 安井 和也, 熊野 健二郎, 吉田 一博, 吉田 龍一, 楳田 祐三, 八木 孝仁

    日本小児外科学会雑誌   58 ( 1 )   124 - 124   2022.2

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • Acute acalculous cholecystitis caused by SARS-CoV-2 infection: A case report and literature review. International journal

    Hana Futagami, Hiroki Sato, Ryuichi Yoshida, Kazuya Yasui, Takahito Yagi, Toshiyoshi Fujiwara

    International journal of surgery case reports   90   106731 - 106731   2022.1

     More details

    Language:English  

    BACKGROUND: Emerging data indicate that gastrointestinal disorders, in addition to pulmonary dysfunction, are also hallmarks of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. CASE PRESENTATION: A 42-year-old man with maintenance hemodialysis developed high fever and dyspnea. He was positive for SARS-CoV-2 and was diagnosed with pneumonia. After treatment for SARS-CoV-2, his respiratory condition improved. However, he developed right upper quadrant pain with elevated inflammatory markers (white blood cells, 21,160/μL; c-reactive protein, 163.9 mg/L) on the 13th day. Abdominal computed tomography revealed acute acalculous cholecystitis. Percutaneous transhepatic gallbladder drainage (PTGBD) was performed together with antibiotic therapy, which resulted in improvement of symptoms. Laparoscopic cholecystectomy was performed 36 days after PTGBD. CONCLUSION: We report a rare case of acute acalculous cholecystitis (AAC) following pneumonia caused by SARS-CoV-2 infection. We also conducted a literature search to characterize SARS-CoV-2-related cholecystitis. Infection with SARS-CoV-2 is an important trigger for AAC, and appropriate therapeutic alternatives should be cautiously selected according to individual cases.

    DOI: 10.1016/j.ijscr.2021.106731

    PubMed

    researchmap

  • Prognostic Value of the Regional Lymph Node Station in Pancreatoduodenectomy for Ampullary Carcinoma. International journal

    Kosei Takagi, Yasuo Nagai, Yuzo Umeda, Ryuichi Yoshida, Kazuhiro Yoshida, Tomokazu Fuji, Kenjiro Kumano, Kazuya Yasui, Takahito Yagi, Toshiyoshi Fujiwara

    In vivo (Athens, Greece)   36 ( 2 )   973 - 978   2022

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND/AIM: The optimal extent of lymph node dissection for ampullary carcinoma is controversial. The aim of this study was to investigate the efficacy of lymph node dissection for ampullary carcinoma. PATIENTS AND METHODS: Between 2000 and 2020, a total of 75 patients undergoing radical resection for ampullary carcinoma were included. The efficacy index (EI) was calculated by multiplication of the frequency of lymph node metastasis (LNM) at the station and the 5-year survival rate of patients with metastasis at the station. RESULTS: Out of 75 patients, 14 had LNM. The EI for the peri-pancreatic head (station 13 and 17) and superior mesenteric artery (station 14) lymph node were 4.4 and 3.5, respectively. Whereas the peri-gastric (station 5 and 6), common hepatic artery (station 8), and liver hilum (station 12) lymph node stations had zero EI. Although the number of patients with the station 16 dissected was small (9%), the para-aortic (station 16) lymph nodes had the highest EI of 14.3 despite being distant lymph nodes. CONCLUSION: We identified the distribution of LNM and survival benefit of lymph node dissection for ampullary carcinoma. Our results suggest that the optimal extent of lymph node dissection for ampullary carcinoma could be reconsidered.

    DOI: 10.21873/invivo.12789

    PubMed

    researchmap

  • Concordance of acquired mutations between metastatic lesions and liquid biopsy in metastatic colorectal cancer. International journal

    Fumitaka Taniguchi, Akihiro Nyuya, Toshiaki Toshima, Kazuya Yasui, Yoshiko Mori, Makoto Okawaki, Hiroyuki Kishimoto, Yuzo Umeda, Toshiyoshi Fujiwara, Hiroaki Tanioka, Yoshiyuki Yamaguchi, Ajay Goel, Takeshi Nagasaka

    Future science OA   7 ( 10 )   FSO757   2021.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Aim: To evaluate whether PCR-reverse sequence-specific oligonucleotide can examine the concordance between liquid biopsy and metastatic lesions with acquired resistance. Materials & methods: We examined acquired mutations in chemoresistant lesions and blood obtained from four patients with RAS wild-type metastatic colorectal cancer who underwent treatment with anti-epidermal growth factor receptor antibodies. Results: In one patient, metastatic lesions harbored diverse acquired mutations in KRAS in all seven metastases; the two acquired mutations were detectable in blood collected after the patient acquired resistance. None of the other patients exhibited liquid biopsy mutations, except one, with a BRAF mutation confirmed in primary tumor and peritoneal dissemination. Conclusion: Liquid biopsy based on PCR-reverse sequence-specific oligonucleotide is a successful procedure for capturing acquired mutations with precise information on the RAS mutational spectrum.

    DOI: 10.2144/fsoa-2021-0059

    PubMed

    researchmap

  • Multiple Hepatolithiasis Following Hepaticojejunostomy Successfully Treated with Left Hemihepatectomy and Double Hepaticojejunostomy Reconstruction.

    Yasuo Nagai, Kosei Takagi, Takashi Kuise, Yuzo Umeda, Ryuichi Yoshida, Kazuhiro Yoshida, Kazuya Yasui, Takahito Yagi, Toshiyoshi Fujiwara

    Acta medica Okayama   75 ( 6 )   735 - 739   2021.12

     More details

    Language:English  

    Surgical intervention for hepatolithiasis following hepaticojejunostomy (HJ) has rarely been reported. Herein, we present a case of post-HJ multiple hepatolithiasis treated with left hemihepatectomy with double HJ reconstruction. A 72-year-old woman who had undergone HJ for iatrogenic bile duct injury developed repeated cholangitis due to complicated hepatolithiasis accompanied by an atrophied left hepatic lobe and HJ stricture. Since endoscopic intervention was unsuccessful, the patient underwent left hemihepatectomy with HJ re-anastomoses of the common hepatic duct and left hepatic duct (double HJ technique). The double HJ technique with hepatectomy can be a useful option for treating complicated hepatolithiasis following HJ.

    DOI: 10.18926/AMO/62814

    PubMed

    researchmap

  • 【conversion surgeryのすべて 切除不能を切除可能に!】切除不能大腸癌肝転移に対するconversion surgery

    楳田 祐三, 高木 弘誠, 藤 智和, 吉田 一博, 安井 和也, 吉田 龍一, 八木 孝仁, 藤原 俊義

    消化器外科   44 ( 13 )   1897 - 1913   2021.12

     More details

    Language:Japanese   Publisher:(株)へるす出版  

    researchmap

  • Technique of vessel-skeletonized parenchyma-sparing hepatectomy for the oncological treatment of bilobar colorectal liver metastases. International journal

    Yuzo Umeda, Takeshi Nagasaka, Kosei Takagi, Ryuichi Yoshida, Kazuhiro Yoshida, Tomokazu Fuji, Tatsuo Matsuda, Kazuya Yasui, Kenjiro Kumano, Hiroki Sato, Takahito Yagi, Toshiyoshi Fujiwara

    Langenbeck's archives of surgery   407 ( 2 )   685 - 697   2021.11

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: To aid in the oncological management of multiple bilobar colorectal liver metastases (CRLMs), we describe a new surgical procedure, VEssel-Skeletonized PArenchyma-sparing Hepatectomy (VESPAH). STUDY DESIGN: Of 152 patients with CRLMs treated with hepatectomy, 33 patients had multiple bilobar liver metastases (≥8 liver metastases); their surgical procedures and clinical outcomes were retrospectively summarized and compared between those who underwent VESPAH and those who underwent major hepatectomy (Major Hx). RESULTS: Of the 33 patients, 20 patients were resected by VESPAH (the VESPAH group) and 13 patients by major hepatectomy (Major Hx group). The median number of CRLMs was 13 (range, 8-53) in the VESPAH group and 10 (range, 8-41) in the Major Hx group (P=0.511). No operative mortality nor severe morbidity was observed in either group. The VESPAH group showed earlier recovery of remnant liver function after surgery than the Major Hx group; the incidence of grade B/C post hepatectomy liver failure was 5% in the VESPAH group and 38% in the Major Hx group, P=0.048). Intrahepatic tumor recurrence was confirmed in 14 (70%) and 7 (54%) patients in the VESPAH and Major Hx groups, respectively (P=0.416). There was no significant difference in median overall survival (OS) after hepatectomy between the two groups; the median OS was 47 months in the VESPAH group and 33 months in the Major Hx group (P=0.481). The VESPAH group showed the higher induction rate of adjuvant chemotherapy within 2 months after surgery (P=0.002) and total number of repeat hepatectomy for intrahepatic recurrence (P=0.060) than the Major Hx group. CONCLUSIONS: VESPAH enables us to clear surgical navigation by hepatic vessel skeletonization and may enhance patient tolerability of not only adjuvant chemotherapy but also repeat hepatectomies during the patients' lifetimes.

    DOI: 10.1007/s00423-021-02373-9

    PubMed

    researchmap

  • Pectoralis major and serratus anterior muscle flap for diaphragmatic reconstruction. International journal

    Toshiyuki Watanabe, Hiroshi Matsumoto, Ryuichi Yoshida, Kazuya Yasui, Takahito Yagi, Yoshihiro Kimata

    The Annals of thoracic surgery   114 ( 1 )   e51-e54   2021.10

     More details

    Language:English  

    The reconstruction of diaphragmatic defects after chondrosarcoma resection is challenging. In diaphragmatic reconstruction with chest wall defects, strong chest wall reconstruction and diaphragmatic flexibility are important to avoid interference with respiration. The artificial material, Gore-Tex, is used as the first choice, but it has infection-, exposure-, and durability-related drawbacks. As an alternative method using artificial material, we present our new alternative technique for diaphragmatic reconstruction using a reversed-combined pectoralis major and serratus anterior muscle flap.

    DOI: 10.1016/j.athoracsur.2021.08.067

    PubMed

    researchmap

  • 先天性胆道拡張症術後46年目に発生し根治切除が可能であった肝門部胆管癌の1例

    吉田 龍一, 野田 卓男, 安井 和也, 佐藤 博紀, 楳田 祐三, 吉田 一博, 藤 智和, 熊野 健二郎, 高木 弘誠, 金平 典之, 納所 洋, 谷本 光隆, 八木 孝仁, 藤原 俊義

    日本膵・胆管合流異常研究会プロシーディングス   44   42 - 43   2021.8

  • 膵・胆管合流異常に対する術後中長期的な経過観察の検討

    熊野 健二郎, 藤 智和, 金平 典之, 佐藤 博紀, 高木 弘誠, 安井 和也, 吉田 一博, 吉田 龍一, 楳田 祐三, 八木 孝仁, 藤原 俊義

    日本膵・胆管合流異常研究会プロシーディングス   44   36 - 36   2021.8

  • Usefulness of Middle Colic Artery Transposition Technique for Hepatic Arterial Reconstruction in Conversion Surgery for an Initially Unresectable, Locally Advanced Pancreatic Cancer.

    Ryuichi Yoshida, Takahito Yagi, Kazuya Yasui, Yuzo Umeda, Kazuhiro Yoshida, Tomokazu Fuji, Kosei Takagi, Kenjiro Kumano, Masashi Yoshimoto, Toshiyoshi Fujiwara

    Acta medica Okayama   75 ( 4 )   543 - 548   2021.8

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    The outcomes of pancreatectomy with resection and reconstruction of the involved arteries for locally advanced pancreatic cancer following chemotherapy have improved in recent years. In pancreatic head cancers in which there is contact with the common and proper hepatic arteries, margin-negative resection requires pancreati-coduodenectomy, with the resection of these arteries and the restoration of hepatic arterial flow. Here, we describe a middle colic artery transposition technique in hepatic arterial reconstruction during pancreatoduo-denectomy for an initially unresectable locally advanced pancreatic cancer. This technique was effective and may provide a new option for hepatic artery reconstruction in such cases.

    DOI: 10.18926/AMO/62410

    PubMed

    researchmap

  • 高度なHCCの治療を目的とする粒子線治療を先行させた肝移植

    八木 孝仁, 吉田 龍一, 安井 和也, 佐藤 博紀, 楳田 祐三, 吉田 一博, 杭瀬 崇, 高木 弘誠, 藤原 俊義

    日本消化器外科学会総会   76回   P143 - 6   2021.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 高齢者に対する肝臓外科治療 高齢者に対する肝切除術前評価における5-Item Modified Frailty Indexの有用性

    吉田 一博, 楳田 祐三, 吉田 龍一, 高木 弘誠, 安井 和也, 黒田 新士, 野間 和広, 香川 俊輔, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   76回   PD5 - 3   2021.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • Pittsburgh styleによるロボット支援下膵頭十二指腸切除術 術式の定型化と手技の工夫

    高木 弘誠, 楳田 祐三, 吉田 龍一, 吉田 一博, 安井 和也, 黒田 新士, 野間 和広, 寺石 文則, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   76回   P147 - 4   2021.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 肝細胞癌治療における肝移植の役割 肝癌肝移植の長期予後に向けて 肝移植適応の選別と再発時治療

    楳田 祐三, 吉田 龍一, 吉田 一博, 高木 弘誠, 安井 和也, 黒田 新士, 野間 和広, 香川 俊輔, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   76回   WS20 - 6   2021.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 進行膵癌集学的治療における術前血中KRAS遺伝子変異の新規バイオマーカーとしての有用性に関する検討

    吉田 龍一, 安井 和也, 楳田 祐三, 吉田 一博, 高木 弘誠, 佐藤 博紀, 黒田 新士, 野間 和広, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   76回   P167 - 3   2021.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 切除可能大腸癌肝転移に対する治療戦略 大腸癌肝転移における術前化学療法の適応選別 RAS/RAF変異による肝外進展リスク

    岡林 弘樹, 楳田 祐三, 吉田 龍一, 吉田 一博, 高木 弘誠, 安井 和也, 黒田 新士, 野間 和広, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   76回   RS24 - 1   2021.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 膵癌術後再発巣に対する局所療法の有用性の検討

    佐藤 博紀, 吉田 龍一, 安井 和也, 楳田 祐三, 吉田 一博, 高木 弘誠, 黒田 新士, 野間 和広, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   76回   P224 - 3   2021.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 切除後再発時期・生存期間に着目した膵癌治療成績の検討 今後の治療方向性を探る

    安井 和也, 吉田 龍一, 佐藤 博紀, 楳田 祐三, 吉田 一博, 高木 弘誠, 黒田 新士, 野間 和広, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   76回   P224 - 4   2021.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • Gastroenteropancreatic neuroendocrine tumor of the accessory papilla of the duodenum: a case report. International journal

    Kosei Takagi, Yuzo Umeda, Ryuichi Yoshida, Kazuhiro Yoshida, Kazuya Yasui, Hiroki Sato, Takahito Yagi, Toshiyoshi Fujiwara

    Surgical case reports   7 ( 1 )   156 - 156   2021.6

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Contrary to the increasing incidence of gastroenteropancreatic neuroendocrine tumors (GEP-NETs), GEP-NETs of the accessory papilla of the duodenum are extremely rare. Furthermore, there have been no recommendations regarding the treatment strategy for GEP-NETs of the accessory papilla of the duodenum. We present a case of GEP-NET of the accessory papilla of the duodenum successfully treated with robotic pancreatoduodenectomy. CASE PRESENTATION: A case of a 70-year-old complaining of no symptoms was diagnosed with GEP-NET of the accessory papilla of the duodenum. A 8-mm tumor was located at the submucosal layer with a biopsy demonstrating a neuroendocrine tumor grade 1. The patient underwent robotic pancreatoduodenectomy as curative resection for the tumor. The total operative time was 406 min with an estimated blood loss of 150 mL. The histological examination revealed a well-differentiated neuroendocrine tumor with low Ki-67 index (< 1%). In the posterior areas of the pancreas, the lymph node metastases were detected. The patient was followed up for 6 months with no recurrence postoperatively. CONCLUSIONS: Considering the potential risks of the lymph node metastases, the standard treatment strategy for GEP-NETs of the accessory papilla of the duodenum should be radical resection with pancreatoduodenectomy. Minimally invasive approach can be the alternative to the conventional open surgery.

    DOI: 10.1186/s40792-021-01241-4

    PubMed

    researchmap

  • Clinical and epigenetic features of colorectal cancer patients with somatic POLE proofreading mutations. International journal

    Takashi Kawai, Akihiro Nyuya, Yoshiko Mori, Takehiro Tanaka, Hiroaki Tanioka, Kazuya Yasui, Toshiaki Toshima, Fumitaka Taniguchi, Kunitoshi Shigeyasu, Yuzo Umeda, Toshiyoshi Fujiwara, Makoto Okawaki, Yoshiyuki Yamaguchi, Ajay Goel, Takeshi Nagasaka

    Clinical epigenetics   13 ( 1 )   117 - 117   2021.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Mutations in the POLE gene result in an ultra-hypermutated phenotype in colorectal cancer (CRC); however, the molecular characterisation of epigenetic alterations remains unclear. We examined the genetic and epigenetic profiles of POLE-mutant CRC to elucidate the clinicopathological features of the associated genetic and epigenetic alterations. RESULTS: Tumour tissues (1,013) obtained from a cohort of patients with CRC were analysed to determine associations between the proofreading domain mutations of POLE with various clinicopathological variables, microsatellite instability (MSI) status, BRAF and KRAS mutations, and the methylation status of key regions of MLH1, MGMT, and SFRP2 promoters by calculating the methylation scores (range 0-6). Only four cases (0.4%) exhibited pathogenic POLE hotspot mutations (two p.P286R [c.857C > G], one p.V411L [c.1231G > C], and p.S459F [c.1376C > T] each), which were mutually exclusive to BRAF and KRAS mutations and MSI. CRC patients were divided into four subgroups: patients with POLE mutations (POLE, 0.4%, n = 4), patients with both MSI and extensive methylation in MLH1 (MSI-M, 2.9%, n = 29), patients with MSI but no extensive methylation in MLH1 (MSI-U, 3.6%, n = 36), and patients without MSI (non-MSI, 93.2%, n = 944). The POLE group was younger at diagnosis (median 52 years, P < 0.0001), with frequent right-sided tumour localisation (frequency of tumours located in the right colon was 100%, 93.1%, 36.1%, and 29.9% in POLE, MSI-M, MSI-U, and non-MSI, respectively; P < 0.0001), and was diagnosed at an earlier stage (frequency of stages I-II was 100%, 72.4%, 77.8%, and 46.6% in POLE, MSI-M, MSI-U, and non-MSI, respectively, P < 0.0001). The mean methylation score in POLE was not different from that in MSI-U and non-MSI, but the methylation signature was distinct from that of the other subgroups. Additionally, although the examined number of POLE-mutant tumours was small, the number of CD8-positive cells increased in tumours with partial methylation in the MLH1 gene. CONCLUSIONS: CRC patients with POLE proofreading mutations are rare. Such mutations are observed in younger individuals, and tumours are primarily located in the right colon. Diagnosis occurs at an earlier stage, and distinct epigenetic alterations may be associated with CD8 cell infiltration.

    DOI: 10.1186/s13148-021-01104-7

    PubMed

    researchmap

  • 外科マネージメントセンターによる情熱のある外科医教育・育成システム

    菊地 覚次, 吉田 龍一, 黒田 新士, 野間 和広, 安井 和也, 笠原 真悟, 豊岡 伸一, 土井原 博義, 藤原 俊義

    日本外科学会定期学術集会抄録集   121回   SP - 6   2021.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 外科における多施設臨床試験の意義と方向性 消化器外科における多施設共同研究の意義 地方からのevidence発信を目指して

    楳田 祐三, 黒田 新士, 香川 俊輔, 吉田 龍一, 菊池 覚次, 杭瀬 崇, 吉田 一博, 高木 弘誠, 安井 和也, 西崎 正彦, 八木 孝仁, 藤原 俊義

    日本外科学会定期学術集会抄録集   121回   NES - 4   2021.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 外科系新専門医制度のあるべきグランドデザイン 地域枠医師に対する外科専門研修のあり方 充実した地域医療の実現を目指して Reviewed

    黒田 新士, 吉田 龍一, 池田 宏国, 岡崎 幹生, 大澤 晋, 小谷 恭弘, 山根 正修, 杉本 誠一郎, 菊地 覚次, 安井 和也, 野田 卓男, 笠原 真悟, 豊岡 伸一, 土井原 博義, 藤原 俊義

    日本外科学会雑誌   122 ( 1 )   83 - 85   2021.1

     More details

    Language:Japanese   Publishing type:Research paper (scientific journal)   Publisher:(一社)日本外科学会  

    researchmap

  • Hemobilia after bile duct resection: perforation of pseudoaneurysm into intra-pancreatic remnant bile duct: a case report. International journal

    Kazuhiro Yoshida, Yuzo Umeda, Masaya Iwamuro, Kazuyuki Matsumoto, Hironari Kato, Mayu Uka, Yusuke Matsui, Ryuichi Yoshida, Takashi Kuise, Kazuya Yasui, Kosei Takagi, Hiroyuki Araki, Takahito Yagi, Toshiyoshi Fujiwara

    BMC surgery   20 ( 1 )   307 - 307   2020.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Hemobilia occurs mainly due to iatrogenic factors such as impairment of the right hepatic or cystic artery, and/or common bile duct in hepatobiliary-pancreatic surgery. However, little or no cases with hemobilia from the intra-pancreatic remnant bile duct after bile duct resection (BDR) has been reported. Here, we report a case of massive hemobilia due to the perforation of psuedoaneurysm of the gastroduodenal artery (GDA) to the intra-pancreatic remnant bile duct after hepatectomy with BDR. CASE PRESENTATION: A 68-year-old male underwent extended right hepatectomy with BDR for gallbladder carcinoma. He presented with upper gastrointestinal bleeding 2 months after the initial surgery. Upper endoscopy identified a blood clot from the ampulla of Vater and simultaneous endoscopic balloon tamponade contributed to temporary hemostasis. Abdominal CT and angiography revealed a perforation of the psuedoaneurysm of the GDA to the intra-pancreatic remnant bile duct resulting in massive hemobilia. Subsequent selective embolization of the pseudoaneurysm with micro-coils could achieve complete hemostasis. He survived without any recurrence of cancer and bleeding. CONCLUSION: Hemobilia could occur in a patient with BDR due to perforation of the pseudoaneurysm derived from the GDA to the intra-pancreatic remnant bile duct. Endoscopic balloon tamponade was useful for a temporal hemostasis and a subsequent radiologic interventional approach.

    DOI: 10.1186/s12893-020-00981-8

    PubMed

    researchmap

  • Short-term and long-term outcomes in living donors for liver transplantation: Cohort study. International journal

    Kosei Takagi, Yuzo Umeda, Ryuichi Yoshida, Nobuyuki Watanabe, Takashi Kuise, Kazuhiro Yoshida, Kazuya Yasui, Tatsuo Matsuda, Toshiyoshi Fujiwara, Takahito Yagi

    International journal of surgery (London, England)   84   147 - 153   2020.12

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: Although perioperative outcomes following donor hepatectomy (DH) have been reported, little is known about the long-term outcomes in living donors of liver transplantation. The aim of this study was to investigate the short-term and long-term outcomes following DH. METHODS: A total of 408 living donors who underwent DH between 1996 and 2019 were analyzed in this retrospective study, focusing on short-term outcomes with respect to the operation period (era) and the graft type, as well as long-term outcomes. RESULTS: The overall incidence of postoperative complications was 40.4%. These included minor (30.4%), major (10.0%), and biliary (14.0%) complications. Short-term outcomes after DH slightly improved over time, and outcomes did not differ significantly between the graft types. With regards to long-term outcomes, the incidence of surgery-related complications such as keloids, incisional hernias, and mechanical bowel obstructions was 6.6% over a median follow-up of 7.2 years. In addition, some donors developed comorbidities such as lifestyle diseases and cancers during the follow-up period. CONCLUSIONS: Our study confirmed an improvement of perioperative outcomes in living donors. There was no significant association between the graft type and postoperative outcomes. Donors could develop various morbidities during long-term follow-up. Therefore, a careful perioperative management and long-term follow-up should be provided to living donors.

    DOI: 10.1016/j.ijsu.2020.11.013

    PubMed

    researchmap

  • A novel modified hanging maneuver in laparoscopic left hemihepatectomy. International journal

    Kosei Takagi, Yuzo Umeda, Takashi Kuise, Ryuichi Yoshida, Kazuhiro Yoshida, Kazuya Yasui, Yuma Tani, Takahito Yagi, Toshiyoshi Fujiwara

    International journal of surgery case reports   76   251 - 253   2020

     More details

    Language:English  

    INTRODUCTION: The liver hanging maneuver is an essential technique for controlling bleeding in hepatectomy, however it is often difficult in laparoscopic major hepatectomy. The present study describes a novel modified hanging maneuver in laparoscopic left hemihepatectomy. PRESENTATION OF CASE: A 29-year-old female underwent laparoscopic left hemihepatectomy for mucinous cystic neoplasm. After mobilizing the left lobe, the liver parenchyma was dissected along the demarcation line. For the hanging technique, the upper edge of the hanging tape was placed on the lateral side of the left hepatic vein, and fixed with the Falciform ligament. The lower edge of the tape was extracted outside the abdomen. Accordingly the hanging tape can be controlled extraperitoneally during the liver parenchyma dissection. DISCUSSION: This technique includes several advantages including no need of assistance using forceps, easy control of the hanging tape extraperitoneally, outflow control, better exposure of surgical field, and helpful guide of the liver dissection line toward the root of the left hepatic vein. CONCLUSION: Our novel modified hanging maneuver is easy and reproducible to use in laparoscopic left hemihepatectomy. Moreover, this technique can be applied to other laparoscopic hepatectomy.

    DOI: 10.1016/j.ijscr.2020.10.002

    PubMed

    researchmap

  • Heterogeneity of Epigenetic and Epithelial Mesenchymal Transition Marks in Hepatocellular Carcinoma with Keratin 19 Proficiency. International journal

    Naosuke Yokomichi, Naoshi Nishida, Yuzo Umeda, Fumitaka Taniguchi, Kazuya Yasui, Toshiaki Toshima, Yoshiko Mori, Akihiro Nyuya, Takehiro Tanaka, Takeshi Yamada, Takahito Yagi, Toshiyoshi Fujiwara, Yoshiyuki Yamaguchi, Ajay Goel, Masatoshi Kudo, Takeshi Nagasaka

    Liver cancer   8 ( 4 )   239 - 254   2019.7

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Objective: Keratin 19 (K19) expression is a potential predictor of poor prognosis in patients with hepatocellular carcinoma (HCC). To clarify the feature of K19-proficient HCC, we traced epigenetic footprints in cultured cells and clinical materials. Patients and Methods: In vitro, KRT19 promoter methylation was analyzed and 5-aza-2'-deoxycytidine with trichostatin A (TSA) treatment was performed. Among 564 surgically resected HCCs, the clinicopathological relevance of K19-proficent HCCs was performed in comparison with hepatocytic (HepPar-1 and arginase-1), epithelial-mesenchymal transition (E-cadherin and vimentin), biliary differentiation-associated (K7 and NOTCH-1) markers, and epigenetic markers (KRT19 promoter/long interspersed nucleotide element-1 [LINE-1] methylation status). Results: KRT19 promoter methylation was clearly associated with K19 deficiency and 5-aza-2'-deoxycytidine with TSA treatment-stimulated K19 re-expression, implicating DNA methylation as a potential epigenetic process for K19 expression. After excluding HCCs with recurrence, TNM stage as IIIB or greater, preoperative therapy, transplantation, and combined hepatocellular cholangiocarcinoma, we assessed 125 of 564 HCC cases. In this cohort, K19 expression was found in 29 HCCs (23.2%) and corresponded with poor survival following surgery (p = 0.025) and extrahepatic recurrence-free survival (p = 0.017). Compared with K19-deficient HCCs, lower KRT19 promoter methylation level was observed in K19-proficient HCCs (p < 0.0001). Conversely, HCC with genome-wide LINE-1 hypermethylation was frequently observed in K19-proficient HCCs (p = 0.0079). Additionally, K19 proficiency was associated with K7 proficiency (p = 0.043), and reduced E-cadherin and HepPar-1 expression (p = 0.043 and p < 0.0001, respectively). Conclusions: K19-proficient HCC exhibited poor prognosis owing to extrahepatic recurrence, with molecular signatures differing from those in conventional cancer stem cells, providing novel insights of the heterogeneity underlying tumor development.

    DOI: 10.1159/000490806

    PubMed

    researchmap

  • Detection of circulating microRNAs with Ago2 complexes to monitor the tumor dynamics of colorectal cancer patients during chemotherapy. International journal

    Tomokazu Fuji, Yuzo Umeda, Akihiro Nyuya, Fumitaka Taniguchi, Takashi Kawai, Kazuya Yasui, Toshiaki Toshima, Kazuhiro Yoshida, Toshiyoshi Fujiwara, Ajay Goel, Takeshi Nagasaka

    International journal of cancer   144 ( 9 )   2169 - 2180   2019.5

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    Because of the different forms of circulating miRNAs in plasma, Argonaute2 (Ago2)-miRNAs and extracellular vesicles (EV-miRNAs), we examined the two forms of extracellular miRNAs in vitro and developed a unique methodology to detect circulating Ago2-miRNAs in small volumes of plasma. We demonstrated that Ago2-miR-21 could be released into the extracellular fluid by active export from viable cancer cells and cytolysis in vitro. As miR-21 and miR-200c were abundantly expressed in both metastatic liver sites and primary lesions, we evaluated Ago2-miR-21 as a candidate biomarker of both active export and cytolysis while Ago2-miR-200c as a biomarker of cytolysis in plasma obtained from colorectal cancer (CRC) patients before treatment and in a series of plasma obtained from CRC patients with liver metastasis who received systemic chemotherapy. The measurement of Ago2-miR-21 allowed us to distinguish CRC patients from subjects without CRC. The trend in ΔCt values for Ago2-miR-21 and -200c during chemotherapy could predict tumor response to ongoing treatment. Thus, capturing circulating Ago2-miRNAs from active export can screen patients with tumor burdens, while capturing them from passive release by cytolysis can monitor tumor dynamics during chemotherapy treatment.

    DOI: 10.1002/ijc.31960

    PubMed

    researchmap

  • 膵腫瘍におけるゲノム解析-病態解明と臨床的意義 包括的アプローチによる浸潤性膵管癌の非侵襲的診断技術の構築

    吉田 一博, 楳田 祐三, 吉田 龍一, 信岡 大輔, 杭瀬 崇, 藤 智和, 安井 和也, Goel Ajay, 八木 孝仁, 藤原 俊義

    膵臓   33 ( 3 )   360 - 360   2018.5

     More details

    Language:Japanese   Publisher:(一社)日本膵臓学会  

    researchmap

  • Clinical outcomes of women with ovarian metastases of colorectal cancer treated with oophorectomy with respect to their somatic mutation profiles. International journal

    Yoshiko Mori, Akihiro Nyuya, Kazuya Yasui, Toshiaki Toshima, Takashi Kawai, Fumitaka Taniguchi, Keisuke Kimura, Ryo Inada, Masahiko Nishizaki, Junko Haraga, Keiichiro Nakamura, Yuzo Umeda, Hiroyuki Kishimoto, Toshiyoshi Fujiwara, Yosuke Katata, Yoshiyuki Yamaguchi, Takeshi Nagasaka

    Oncotarget   9 ( 23 )   16477 - 16488   2018.3

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    We clarified the clinical prevalence of ovarian metastases from colorectal cancers (CRCs) in 296 female patients with CRC and evaluated clinical outcomes with relation to their mutational profiles, such as BRAF/KRAS mutation and microsatellite instability (MSI) status. The female CRCs were categorised into three subsets: CRCs with ovarian metastases [6.4% (n = 19), 5-year overall survival (OS) = 24.7%], CRCs with extra-ovarian metastases only [32.4% (n = 96), 5-year OS = 34.5%] and CRCs without any recurrence or metastasis [61.2% (n = 181), 5-year OS = 91.3%]. All patients with ovarian metastases underwent oophorectomy; of these, 9 who received preoperative chemotherapy had measurable metastases to extra-ovarian sites and the ovaries. Although 5 of 9 (56%) achieved partial response or complete response at extra-ovarian sites, no patient archived objective response at ovarian sites. Regarding the mutation profiles, in CRCs with extra-ovarian metastases only, the median survival time (MST) after initial treatments to progression to stage IV or recurrence was 13 [95% confidence interval (CI): 7-16 months] in BRAF-mutant and 34 months (95% CI: 22-58 months) in BRAF wild-type (P = 0.0033). Although ovarian metastases demonstrated poor response to systemic chemotherapy in CRCs with ovarian metastases, the MST after initial treatments to progression to stage IV or recurrence was 22 (95% CI: 21-25 months) in BRAF-mutant and 38 months (95% CI: 24-42 months) in BRAF wild-type (P = 0.0398). The outcomes of patients with ovarian metastases could be improved by oophorectomy regardless of their mutation profiles.

    DOI: 10.18632/oncotarget.24735

    PubMed

    researchmap

  • Ovarian metastasectomy in colorectal cancer may improve the clinical outcomes of patients with metastatic colorectal cancer regardless of BRAF or KRAS mutational profiles

    Mori Yoshiko, Nagasaka Takeshi, Tanioka Hiroaki, Nyuya Akihiro, Kawai Takashi, Toshima Toshiaki, Yasui Kazuya, Shigeyasu Kunitoshi, Kishimoto Hiroyuki, Umeda Yuzo, Fujiwara Toshiyoshi

    ANNALS OF ONCOLOGY   28   2017.6

     More details

    Language:English   Publisher:OXFORD UNIV PRESS  

    Web of Science

    researchmap

  • Stage IV大腸癌に対するPrecision Medicineの構築

    河合 毅, 永坂 岳司, 母里 淑子, 楳田 祐三, 稲田 涼, 谷口 文崇, 安井 和也, 戸嶋 俊明, 岸本 浩行, 藤原 俊義

    日本外科学会定期学術集会抄録集   117回   SF - 1   2017.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 胆道 胆道がんの手術療法 肝内胆管癌に対する外科治療 リンパ節郭清の意義

    楳田 祐三, 八木 孝仁, 永坂 岳司, 篠浦 先, 吉田 龍一, 信岡 大輔, 渡辺 信之, 藤 智和, 安井 和也, 藤原 俊義

    日本癌治療学会学術集会抄録集   54回   WS40 - 1   2016.10

     More details

    Language:Japanese   Publisher:(一社)日本癌治療学会  

    researchmap

  • 転移性大腸癌における治療標的となりうるマイクロRNAの同定

    河合 毅, 永坂 岳司, 藤 智和, 戸嶋 俊明, 安井 和也, 母里 淑子, 藤原 俊義

    日本癌学会総会記事   75回   P - 1273   2016.10

     More details

    Language:English   Publisher:(一社)日本癌学会  

    researchmap

  • IDH1/2およびKRAS遺伝子の変異ステータスによる肝内胆管癌の層別化

    安井 和也, 永坂 岳司, 楳田 祐三, 藤 智和, 戸嶋 俊明, 河合 毅, 母里 淑子, 八木 孝仁, 藤原 俊義

    日本癌学会総会記事   75回   P - 1306   2016.10

     More details

    Language:English   Publisher:(一社)日本癌学会  

    researchmap

  • circulating cell free DNAのメチル化解析による大腸癌化学療法の治療効果判定の診断

    戸嶋 俊明, 永坂 岳司, 木村 圭佑, 安井 和也, 河合 毅, 母里 淑子, 藤原 俊義

    日本癌学会総会記事   75回   P - 1071   2016.10

     More details

    Language:English   Publisher:(一社)日本癌学会  

    researchmap

  • 膵癌切除症例における免疫チェックポイント分子の発現解析 膵癌切除例とTCGA dataを対象とした免疫チェックポイント機構の解析

    藤 智和, 楳田 祐三, 永坂 岳司, 母里 淑子, 谷口 文崇, 安井 和也, 河合 毅, 八木 孝仁, 藤原 俊義

    日本外科学会定期学術集会抄録集   116回   OP - 1   2016.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 術前内照射および化学療法が著効し、根治切除し得た巨大異所性褐色細胞腫の1例

    安井 和也, 楳田 祐三, 熊野 健二郎, 田端 雅弘, 大塚 文男, 八木 孝仁, 藤原 俊義

    岡山医学会雑誌   127 ( 3 )   213 - 218   2015.12

     More details

    Language:Japanese   Publisher:岡山医学会  

    症例は46歳男性で、健診で便潜血陽性を指摘され、上下部内視鏡検査で大腸ポリープが散在するのみで腫瘍性病変は指摘できず、腹部CTで大動脈右側に14cm大の後腹膜腫瘍を認めた。血圧166/96mmHg、脈拍68回/分・整で、腫瘤は触れず、血液生化学検査・甲状腺機能に異常なかった。腫瘍マーカーはCEA 4.6ng/ml、CA19-9 9.2U/ml、AFP 7.8ng/ml、PIVKA-II 31AU/mlでいずれも正常範囲であった。血液中ノルアドレナリンは12.4ng/mlと上昇し、ドーパミン値も24.0ng/mlと高値、血液中アドレナリン値は0.04ng/mlと正常であった。腹部造影CTで右横隔膜下から右腎下極にかけ比較的境界明瞭な14×12×7cmの腫瘤が存在し、造影早期より強く濃染され、腫瘍内部は壊死像を呈した。下大静脈を右側に圧排し、膵臓を腹側に圧排していた。門脈は狭小化し、側副血行路が発達していた。131I-MIGBシンチグラフィーでCTで指摘された腫瘤に一致し集積が亢進していた。遠隔転移を疑う他部位への集積はみられなかった。異所性褐色細胞腫と診断し、根治切除について検討したが、肝臓や十二指腸、膵頭部上腸間膜動脈周囲、さらに右腎動脈などの合併切除を要する可能性があるため、根治切除は不可能と判断し、腫瘍の縮小による根治切除の可能性について検討し、131I-MIGB内照射療法を施行した。CTで軽度縮小効果は得られたが血中アドレナリン値上昇傾向であったため内照射療法を終了し化学療法(CVD療法)を行った。腫瘍の縮小に伴い血中カテコールアミン値も減少した。根治切除を目的に手術を施行した。右斜胸腹部切開で開腹し、腫瘍は肝十二指腸間膜や十二指腸下行脚を圧排して存在していた。術後経過は良好で術後23日目に退院し、術後10ヵ月、降圧薬を使用せず血圧は正常範囲で推移し、血液中ノルアドレナリン値も正常値に改善し再発なく経過している。

    researchmap

    Other Link: https://search.jamas.or.jp/index.php?module=Default&action=Link&pub_year=2015&ichushi_jid=J00175&link_issn=&doc_id=20151221140005&doc_link_id=10.4044%2Fjoma.127.213&url=https%3A%2F%2Fdoi.org%2F10.4044%2Fjoma.127.213&type=J-STAGE&icon=https%3A%2F%2Fjk04.jamas.or.jp%2Ficon%2F00007_3.gif

  • 血中のcirculating cell-freeDNAのメチル化検出による大腸癌の同定

    戸嶋 俊明, 永坂 岳司, 河合 毅, 藤 智和, 谷口 文崇, 木村 圭佑, 安井 和也, 母里 淑子, 藤原 俊義

    日本癌学会総会記事   74回   P - 2007   2015.10

     More details

    Language:English   Publisher:(一社)日本癌学会  

    researchmap

  • 膵嚢胞性疾患の治療方針 遺伝子変異解析によるIPMN悪性度診断の新展開

    安井 和也, 楳田 祐三, 永坂 岳司, 吉田 一博, 藤 智和, 篠浦 先, 吉田 龍一, 信岡 大輔, 杭瀬 崇, 八木 孝仁, 藤原 俊義

    日本肝胆膵外科学会・学術集会プログラム・抄録集   27回   387 - 387   2015.6

     More details

    Language:Japanese   Publisher:(一社)日本肝胆膵外科学会  

    researchmap

  • Genetic and epigenetic alterations of netrin-1 receptors in gastric cancer with chromosomal instability. International journal

    Keisuke Toda, Takeshi Nagasaka, Yuzo Umeda, Takehiro Tanaka, Takashi Kawai, Tomokazu Fuji, Fumitaka Taniguchi, Kazuya Yasui, Nobuhito Kubota, Yuko Takehara, Hiroshi Tazawa, Shunsuke Kagawa, Dong-Sheng Sun, Naoshi Nishida, Ajay Goel, Toshiyoshi Fujiwara

    Clinical epigenetics   7 ( 1 )   73 - 73   2015

     More details

    Language:English   Publishing type:Research paper (scientific journal)  

    BACKGROUND: The gene expressions of netrin-1 dependence receptors, DCC and UNC5C, are frequently downregulated in many cancers. We hypothesized that downregulation of DCC and UNC5C has an important growth regulatory function in gastric tumorigenesis. RESULTS: In the present study, a series of genetic and epigenetic analyses for DCC and UNC5C were performed in a Japanese cohort of 98 sporadic gastric cancers and corresponding normal gastric mucosa specimens. Loss of heterozygosity (LOH) analyses and microsatellite instability (MSI) analysis was applied to determine chromosomal instability (CIN) and MSI phenotypes, respectively. More than 5 % methylation in the DCC and UNC5C promoters were found in 45 % (44/98) and 32 % (31/98) gastric cancers, respectively, and in 9 % (9/105) and 5 % (5/105) normal gastric mucosa, respectively. Overall, 70 % (58 of 83 informative cases) and 51 % (40 of 79 informative cases) of gastric cancers harbored either LOH or aberrant methylation in the DCC and UNC5C genes, respectively. In total, 77 % (51 of 66 informative cases) of gastric cancers showed cumulative defects in these two dependence receptors and were significantly associated with chromosomal instability. Both DCC and UNC5C were inactivated in 97 % of CIN-positive gastric cancers and in 55 % of CIN-negative gastric cancers. CONCLUSIONS: Defect in netrin receptors is a common feature in gastric cancers. DCC alterations are apparent in the early stages, and UNC5C alterations escalate with the progression of the disease, suggesting that the cumulative alterations of netrin-1 receptors was a late event in gastric cancer progression and emphasizing the importance of this growth regulatory pathway in gastric carcinogenesis.

    DOI: 10.1186/s13148-015-0096-y

    PubMed

    researchmap

  • 胃癌術後にリンパ節再発が疑われた後腹膜デスモイド腫瘍の1例

    稲葉 基高, 高畑 隆臣, 木村 臣一, 安井 和也, 前田 直見

    日本消化器外科学会雑誌   43 ( Suppl.2 )   236 - 236   2010.10

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

▼display all

MISC

  • 循環遊離DNAメチル化パターンは原発腫瘍変異プロファイルなしに大腸癌検出とモニタリングを可能とする

    永坂岳司, 戸嶋俊明, 稲田凉, 安井和也, 楳田祐三, 岡脇誠, 入谷光洋, 矢野修也, 谷岡洋亮, 山田岳史, 猶本良夫

    日本大腸肛門病学会雑誌(Web)   76 ( 9 )   2023

  • 肝細胞癌治療における肝移植の役割 肝癌肝移植の長期予後に向けて 肝移植適応の選別と再発時治療

    楳田 祐三, 吉田 龍一, 吉田 一博, 高木 弘誠, 安井 和也, 黒田 新士, 野間 和広, 香川 俊輔, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   76回   WS20 - 6   2021.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 高齢者に対する肝臓外科治療 高齢者に対する肝切除術前評価における5-Item Modified Frailty Indexの有用性

    吉田 一博, 楳田 祐三, 吉田 龍一, 高木 弘誠, 安井 和也, 黒田 新士, 野間 和広, 香川 俊輔, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   76回   PD5 - 3   2021.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • Pittsburgh styleによるロボット支援下膵頭十二指腸切除術 術式の定型化と手技の工夫

    高木 弘誠, 楳田 祐三, 吉田 龍一, 吉田 一博, 安井 和也, 黒田 新士, 野間 和広, 寺石 文則, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   76回   P147 - 4   2021.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 高度なHCCの治療を目的とする粒子線治療を先行させた肝移植

    八木 孝仁, 吉田 龍一, 安井 和也, 佐藤 博紀, 楳田 祐三, 吉田 一博, 杭瀬 崇, 高木 弘誠, 藤原 俊義

    日本消化器外科学会総会   76回   P143 - 6   2021.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 切除後再発時期・生存期間に着目した膵癌治療成績の検討 今後の治療方向性を探る

    安井 和也, 吉田 龍一, 佐藤 博紀, 楳田 祐三, 吉田 一博, 高木 弘誠, 黒田 新士, 野間 和広, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   76回   P224 - 4   2021.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 進行膵癌集学的治療における術前血中KRAS遺伝子変異の新規バイオマーカーとしての有用性に関する検討

    吉田 龍一, 安井 和也, 楳田 祐三, 吉田 一博, 高木 弘誠, 佐藤 博紀, 黒田 新士, 野間 和広, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   76回   P167 - 3   2021.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 膵癌術後再発巣に対する局所療法の有用性の検討

    佐藤 博紀, 吉田 龍一, 安井 和也, 楳田 祐三, 吉田 一博, 高木 弘誠, 黒田 新士, 野間 和広, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   76回   P224 - 3   2021.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 切除可能大腸癌肝転移に対する治療戦略 大腸癌肝転移における術前化学療法の適応選別 RAS/RAF変異による肝外進展リスク

    岡林 弘樹, 楳田 祐三, 吉田 龍一, 吉田 一博, 高木 弘誠, 安井 和也, 黒田 新士, 野間 和広, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   76回   RS24 - 1   2021.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 胆道閉鎖症患児の黄疸重症度が生体肝移植に及ぼす影響

    畑 七々子, 藤 智和, 松田 達雄, 安井 和也, 吉田 一博, 杭瀬 崇, 吉田 龍一, 楳田 祐三, 八木 孝仁

    日本小児外科学会雑誌   57 ( 4 )   794 - 794   2021.6

     More details

    Language:Japanese   Publisher:(一社)日本小児外科学会  

    researchmap

  • 【各施設での胆膵疾患に対する診療科横断的チーム医療】岡山大学病院における膵癌に対する集学的治療と肝移植後の胆管狭窄に対する内視鏡治療の診療科横断的な取り組み

    加藤 博也, 安井 和也, 吉田 龍一, 楳田 祐三, 宇賀 麻由, 田中 健大, 八木 孝仁, 岡田 裕之

    胆と膵   42 ( 5 )   457 - 462   2021.5

     More details

    Language:Japanese   Publisher:医学図書出版(株)  

    岡山大学病院では胆膵疾患診療に対する診療科横断的なチーム医療を積極的に行っている。膵癌の集学的治療においては、術前後の化学療法は内科が担当し、周術期においては外科、麻酔科、歯科などの医師のみならず、看護師、理学療法士、薬剤師などからなる周術期管理センターが患者のサポートにあたる。術後には病理を検討するカンファレンスを行い、外科、内科、放射線科、病理診断科の医師が一堂に会して症例の振り返りを行い明日への診療に役立てている。肝移植後の胆管狭窄はしばしば患者の予後にかかわるものであり、積極的な治療介入が必要である。当院では移植開始当初から術後胆管狭窄に対し内視鏡治療を行ってきた。肝移植の胆道再建は症例ごとに異なるので、内視鏡治療前の外科との協議による情報収集が重要である。また、胆管炎が起こった際などは免疫抑制剤の調整が必要であり、内視鏡治療前後の管理は外科が行っている。(著者抄録)

    researchmap

  • 外科マネージメントセンターによる情熱のある外科医教育・育成システム

    菊地 覚次, 吉田 龍一, 黒田 新士, 野間 和広, 安井 和也, 笠原 真悟, 豊岡 伸一, 土井原 博義, 藤原 俊義

    日本外科学会定期学術集会抄録集   121回   SP - 6   2021.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 進行胆嚢癌に対する外科治療 手術成績を踏まえ、その限界を考える

    吉田 一博, 楳田 祐三, 吉田 龍一, 杭瀬 崇, 安井 和也, 高木 弘誠, 荒木 宏之, 谷 悠真, 實金 悠, 八木 孝仁, 藤原 俊義

    日本外科学会定期学術集会抄録集   121回   PS - 7   2021.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • ロボット支援下膵頭十二指腸切除術の安全な導入と術式の定型化

    高木 弘誠, 楳田 祐三, 吉田 龍一, 杭瀬 崇, 吉田 一博, 安井 和也, 八木 孝仁, 藤原 俊義

    日本外科学会定期学術集会抄録集   121回   PS - 5   2021.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • T1/T2膵癌の術前治療適応に関する検討 多施設共同後方視的研究

    吉田 龍一, 日置 勝義, 須井 健太, 佐藤 太佑, 児島 亨, 國府島 健, 安井 和也, 八木 孝仁, 藤原 俊義

    日本外科学会定期学術集会抄録集   121回   SF - 2   2021.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 外科における多施設臨床試験の意義と方向性 消化器外科における多施設共同研究の意義 地方からのevidence発信を目指して

    楳田 祐三, 黒田 新士, 香川 俊輔, 吉田 龍一, 菊池 覚次, 杭瀬 崇, 吉田 一博, 高木 弘誠, 安井 和也, 西崎 正彦, 八木 孝仁, 藤原 俊義

    日本外科学会定期学術集会抄録集   121回   NES - 4   2021.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • R/BR膵癌術前化学療法施行症例における術直前CA19-9値の意義に関する検討

    安井 和也, 吉田 龍一, 楳田 祐三, 杭瀬 崇, 吉田 一博, 高木 弘誠, 八木 孝仁, 藤原 俊義

    日本外科学会定期学術集会抄録集   121回   PS - 4   2021.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 外科系新専門医制度のあるべきグランドデザイン 地域枠医師に対する外科専門研修のあり方 充実した地域医療の実現を目指して

    黒田 新士, 吉田 龍一, 池田 宏国, 岡崎 幹生, 大澤 晋, 小谷 恭弘, 山根 正修, 杉本 誠一郎, 菊地 覚次, 安井 和也, 野田 卓男, 笠原 真悟, 豊岡 伸一, 土井原 博義, 藤原 俊義

    日本外科学会雑誌   122 ( 1 )   83 - 85   2021.1

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 局所進行切除不能膵癌における予後規定因子の検討 非切除例を含めたall cohort解析

    安井 和也, 吉田 龍一, 楳田 祐三, 杭瀬 崇, 吉田 一博, 高木 弘誠, 松田 達雄, 荒木 宏之, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   75回   O16 - 2   2020.12

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 切除可能膵癌における術後早期再発予測因子の解析 多施設共同後方視的研究

    須井 健太, 吉田 龍一, 日置 勝義, 佐藤 太祐, 児島 亨, 國府島 健, 久保 孝文, 安井 和也, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   75回   RS19 - 1   2020.12

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 膵頭十二指腸切除術における周術期栄養療法のエビデンス

    高木 弘誠, 楳田 祐三, 吉田 龍一, 杭瀬 崇, 吉田 一博, 安井 和也, 松田 達雄, 荒木 宏之, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   75回   O17 - 6   2020.12

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 切除可能/切除可能境界膵癌における術前後血中KRAS遺伝子変異検出とその意義に関する検討

    吉田 龍一, 安井 和也, 楳田 祐三, 杭瀬 崇, 吉田 一博, 松田 達雄, 高木 弘誠, 荒木 宏之, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   75回   P276 - 4   2020.12

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 肝癌に対する肝移植の長期成績と再発予防 肝癌肝移植の長期予後に向けて 肝移植適応の選別と再発時治療

    楳田 祐三, 吉田 龍一, 杭瀬 崇, 吉田 一博, 高木 弘誠, 安井 和也, 荒木 宏之, 八木 孝仁, 藤原 俊義

    日本臨床外科学会雑誌   81 ( 増刊 )   246 - 246   2020.10

     More details

    Language:Japanese   Publisher:日本臨床外科学会  

    researchmap

  • CDDP+VP-16療法を根治術後に施行し長期無再発生存している十二指腸乳頭部MANECの1例

    谷 悠真, 杭瀬 崇, 堀口 繁, 實金 悠, 荒木 宏之, 高木 弘誠, 安井 和也, 吉田 一博, 吉田 龍一, 楳田 祐三, 八木 孝仁, 藤原 俊義

    日本癌治療学会学術集会抄録集   58回   P - 194   2020.10

     More details

    Language:Japanese   Publisher:(一社)日本癌治療学会  

    researchmap

  • 術前臨床情報を用いた切除可能膵癌の層別化 多施設共同後方視的研究

    佐藤 太佑, 吉田 龍一, 日置 勝義, 須井 健太, 児島 亨, 國府島 健, 久保 孝文, 安井 和也, 八木 孝仁, 藤原 俊義

    日本臨床外科学会雑誌   81 ( 増刊 )   331 - 331   2020.10

     More details

    Language:Japanese   Publisher:日本臨床外科学会  

    researchmap

  • 一人前の肝胆膵外科医をめざして 中堅肝胆膵外科医からみる岡山大学育成システムの回顧と展望

    杭瀬 崇, 楳田 祐三, 吉田 龍一, 吉田 一博, 藤 智和, 安井 和也, 松田 達雄, 畑 七々子, 八木 千晶, 白川 靖博, 八木 孝仁, 藤原 俊義

    日本外科学会定期学術集会抄録集   120回   SSF - 2   2020.8

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 肝動脈浸潤を伴う局所進行切除不能膵頭部癌に対する膵頭十二指腸切除術 結腸動脈を用いた肝動脈再建の適応と手術手技

    安井 和也, 吉田 龍一, 楳田 祐三, 杭瀬 崇, 吉田 一博, 藤 智和, 松田 達雄, 畑 七々子, 八木 千晶, 八木 孝仁, 藤原 俊義

    日本外科学会定期学術集会抄録集   120回   DP - 5   2020.8

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 脳死肝移植マージナルドナーの移植予後の解明と活用への提言

    吉田 一博, 楳田 祐三, 吉田 龍一, 杭瀬 崇, 藤 智和, 安井 和也, 松田 達雄, 畑 七々子, 八木 千晶, 八木 孝仁, 白川 靖博, 藤原 俊義

    日本外科学会定期学術集会抄録集   120回   SF - 4   2020.8

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 大腸癌以外の肝転移の切除成績 切除適応を見極める

    畑 七々子, 藤 智和, 楳田 祐三, 吉田 龍一, 杭瀬 崇, 吉田 一博, 安井 和也, 白川 靖博, 八木 孝仁, 藤原 俊義

    日本外科学会定期学術集会抄録集   120回   DP - 6   2020.8

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 我が国の肝移植医療の実力と未来【International】生体肝移植における有望な外科的イノベーション技術と周術期管理(Promising surgical innovation and perioperative management in living donor liver transplantation)

    楳田 祐三, 八木 孝仁, 吉田 龍一, 杭瀬 崇, 吉田 一博, 藤 智和, 安井 和也, 松田 達雄, 白川 靖博, 藤原 俊義

    日本外科学会定期学術集会抄録集   120回   SY - 3   2020.8

     More details

    Language:English   Publisher:(一社)日本外科学会  

    researchmap

  • 地域枠医師に対する外科専門研修のあり方 充実した地域医療の実現を目指して

    黒田 新士, 吉田 龍一, 池田 宏国, 岡崎 幹生, 大澤 晋, 小谷 恭弘, 山根 正修, 杉本 誠一郎, 菊地 覚次, 安井 和也, 野田 卓男, 笠原 真悟, 豊岡 伸一, 土井原 博義, 藤原 俊義

    日本外科学会定期学術集会抄録集   120回   SP - 4   2020.8

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 局所進行膵癌治療中のliquid biopsyによるKRAS遺伝子変異検出とCA19-9値推移の意義に関する検討

    吉田 龍一, 安井 和也, 楳田 祐三, 杭瀬 崇, 吉田 一博, 藤 智和, 松田 達雄, 八木 孝仁, 藤原 俊義

    日本外科学会定期学術集会抄録集   120回   SF - 4   2020.8

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 肝内胆管癌における免疫微小環境と治療予後の関連性

    小西 大輔, 吉田 一博, 楳田 祐三, 重安 邦俊, 矢野 修也, 武田 正, 吉田 龍一, 杭瀬 崇, 藤 智和, 安井 和也, 松田 達雄, 田澤 大, 白川 靖博, 八木 孝仁, 藤原 俊義

    日本外科学会定期学術集会抄録集   120回   SF - 3   2020.8

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 希少脾腫瘍の2例 SANT(sclerosing angiomatoid nodular transformation)とIPT(inflammatory pseudotumor)

    村田 光隆, 杭瀬 崇, 畑 七々子, 八木 千晶, 松田 達雄, 安井 和也, 藤 智和, 吉田 一博, 吉田 龍一, 楳田 祐三, 八木 孝仁, 藤原 俊義

    日本臨床外科学会雑誌   81 ( 6 )   1203 - 1203   2020.6

     More details

    Language:Japanese   Publisher:日本臨床外科学会  

    researchmap

  • 局所進行切除不能膵癌conversion surgeryにおける結腸動脈を用いた肝動脈再建

    吉田龍一, 楳田祐三, 杭瀬崇, 吉田一博, 安井和也, 高木弘誠, 荒木宏之, 八木孝仁, 藤原俊義

    日本膵切研究会プログラム・抄録集   47th   2020

  • 抗EGFR抗体によるRAS野生型大腸癌獲得変異に対する検討

    永坂 岳司, 入谷 光洋, 谷口 文崇, 戸嶋 俊明, 安井 和也, 母里 淑子, 楳田 祐三, 岸本 浩行, 河合 毅, 山口 佳之

    日本癌治療学会学術集会抄録集   57回   O23 - 4   2019.10

     More details

    Language:English   Publisher:(一社)日本癌治療学会  

    researchmap

  • プラスティックステントによる悪性遠位胆管狭窄の術前ドレナージの検討

    高田 斎文, 吉田 龍一, 安井 和也, 加藤 博也, 松三 明宏, 石原 祐基, 皿谷 洋祐, 室 信一郎, 内田 大輔, 友田 健, 堀口 繁, 八木 孝仁, 岡田 裕之

    Gastroenterological Endoscopy   61 ( Suppl.2 )   2191 - 2191   2019.10

     More details

    Language:Japanese   Publisher:(一社)日本消化器内視鏡学会  

    researchmap

  • 大腸癌におけるリキッドバイオプシーの有用性 血中遊離メチル化DNAをバイオマーカーに用いたLiquid Biopsyによる大腸癌診断の可能性

    永坂 岳司, 入谷 光洋, 戸嶋 俊明, 安井 和也, 稲田 涼, 母里 淑子, 重安 邦俊, 楳田 祐三, 岸本 浩行, 山口 佳之

    日本大腸肛門病学会雑誌   72 ( 9 )   A76 - A76   2019.9

     More details

    Language:Japanese   Publisher:(一社)日本大腸肛門病学会  

    researchmap

  • 医原性胆道損傷に対する修復術 Immediate repairと手技の要点

    杭瀬 崇, 楳田 祐三, 松田 達雄, 安井 和也, 藤 智和, 吉田 一博, 吉田 龍一, 白川 靖博, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   74回   P214 - 5   2019.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 【肝胆膵】大腸癌原発でない転移性肝癌に対する肝切除の適応と治療成績 非大腸癌・非内分泌腫瘍由来肝転移の切除成績 切除適応となる癌腫を見極める

    梶原 義典, 藤 智和, 楳田 祐三, 吉田 龍一, 杭瀬 崇, 吉田 一博, 安井 和也, 白川 靖博, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   74回   WS29 - 2   2019.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 【肝】肝移植ハイリスク患者への挑戦 生体肝移植におけるハイリスク症例 MELDは移植予後を反映するか

    楳田 祐三, 八木 孝仁, 吉田 龍一, 杭瀬 崇, 吉田 一博, 藤 智和, 松田 達雄, 安井 和也, 白川 靖博, 藤原 俊義

    日本消化器外科学会総会   74回   PD4 - 4   2019.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • BR/UR膵癌における末梢血中KRAS遺伝子変異の新規バイオマーカーとしての有用性に関する検討

    吉田 龍一, 楳田 祐三, 杭瀬 崇, 吉田 一博, 藤 智和, 安井 和也, 松田 達雄, 香川 俊輔, 八木 孝仁, 藤原 俊儀

    日本消化器外科学会総会   74回   O41 - 2   2019.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 【肝胆膵】肝移植と合併症対策 生体肝移植後における脾動脈盗血症候群に対する治療介入の意義

    松田 達雄, 楳田 祐三, 吉田 一博, 安井 和也, 藤 智和, 杭瀬 崇, 吉田 龍一, 白川 靖博, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   74回   WS12 - 7   2019.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 膵IPMN術後残膵再発累積リスクに着目した術後至適surveillance法の検討

    藤 智和, 楳田 祐三, 安井 和也, 吉田 一博, 杭瀬 崇, 吉田 龍一, 白川 靖博, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   74回   P237 - 2   2019.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 再肝切除における根治性確保と合併症軽減に向けた工夫

    吉田 一博, 楳田 祐三, 吉田 龍一, 杭瀬 崇, 藤 智和, 松田 達雄, 安井 和也, 白川 靖博, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   74回   O10 - 7   2019.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 切除可能膵頭部癌における早期再発予測因子と転移形式の解析

    安井 和也, 吉田 龍一, 楳田 祐三, 杭瀬 崇, 吉田 一博, 藤 智和, 松田 達雄, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   74回   P246 - 5   2019.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • Primary Tumor LocationとGenetic/Epigenetic変異分布不均衡に対する検討

    永坂 岳司, 堅田 洋佑, 岡脇 誠, 山村 真弘, 母里 淑子, 安井 和也, 戸嶋 俊明, 岸本 浩行, 藤原 俊儀, 山口 佳之

    日本大腸肛門病学会雑誌   72 ( 5 )   291 - 291   2019.5

     More details

    Language:Japanese   Publisher:(一社)日本大腸肛門病学会  

    researchmap

  • 便中メチル化CpG検出による非侵襲的大腸癌スクリーング技術の実用化を目指して

    永坂 岳司, 母里 淑子, 入谷 光洋, 安井 和也, 戸嶋 俊明, 河合 毅, 重安 邦俊, 谷口 文崇, 藤 智和, 楳田 祐三, 岸本 浩行, 藤原 俊儀

    日本大腸肛門病学会雑誌   72 ( 5 )   244 - 244   2019.5

     More details

    Language:Japanese   Publisher:(一社)日本大腸肛門病学会  

    researchmap

  • MELD scoreによる生体肝移植の術後解析 生体肝移植におけるMELD/重症度に応じたDonor/Graft選択の重要性

    楳田 祐三, 八木 孝仁, 吉田 龍一, 杭瀬 崇, 吉田 一博, 藤 智和, 安井 和也, 松田 達雄, 白川 靖博, 香川 俊輔, 藤原 俊義

    日本外科学会定期学術集会抄録集   119回   PD - 3   2019.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 肝移植患者の移植後二次発癌

    松田 達雄, 楳田 祐三, 吉田 一博, 吉田 龍一, 野間 和広, 信岡 大輔, 田辺 俊介, 杭瀬 崇, 前田 直見, 安井 和也, 白川 靖博, 八木 孝仁, 藤原 俊義

    日本外科学会定期学術集会抄録集   119回   PS - 2   2019.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 血中遊離メチル化DNA測定による早期診断、術後再発予測、病勢予測

    戸嶋 俊明, 永坂 岳司, 入谷 光洋, 安井 和也, 吉田 一博, 稲田 涼, 楳田 祐三, 藤原 俊義

    日本外科学会定期学術集会抄録集   119回   SF - 2   2019.4

     More details

    Language:Japanese   Publisher:(一社)日本外科学会  

    researchmap

  • 下大静脈腫瘍栓を有する巨大肝細胞癌に対し積極的な肝切除を施行した2例

    岡 凌也, 信岡 大輔, 小西 大輔, 西山 岳芳, 田渕 幹康, 安井 和也, 吉田 一博, 杭瀬 崇, 吉田 龍一, 楳田 祐三, 八木 孝仁, 藤原 俊義

    日本臨床外科学会雑誌   80 ( 3 )   606 - 606   2019.3

     More details

    Language:Japanese   Publisher:日本臨床外科学会  

    researchmap

  • 抗EGFR抗体によるRAS野生型大腸癌獲得変異に対する検討

    永坂岳司, 入谷光洋, 谷口文崇, 戸嶋俊明, 安井和也, 母里淑子, 楳田祐三, 岸本浩行, 河合毅, 山口佳之

    日本癌治療学会学術集会(Web)   57th   2019

  • 遠隔転移を有する膵神経内分泌腫瘍の治療戦略 膵神経内分泌腫瘍(panNEN)における、肝転移症例の検討と外科的治療戦略

    田渕 幹康, 杭瀬 崇, 西山 岳芳, 安井 和也, 吉田 一博, 信岡 大輔, 吉田 龍一, 楳田 祐三, 八木 孝仁, 藤原 俊義

    日本臨床外科学会雑誌   79 ( 増刊 )   332 - 332   2018.10

     More details

    Language:Japanese   Publisher:日本臨床外科学会  

    researchmap

  • 膵鈎部癌に対する上腸間膜動脈周囲郭清の郭清手技 腫瘍進展に基づいたleft-lateral approach

    吉田 一博, 楳田 祐三, 吉田 龍一, 信岡 大輔, 杭瀬 崇, 安井 和也, 田渕 幹康, 西山 岳芳, 白川 靖博, 八木 孝仁, 藤原 俊義

    日本臨床外科学会雑誌   79 ( 増刊 )   448 - 448   2018.10

     More details

    Language:Japanese   Publisher:日本臨床外科学会  

    researchmap

  • 抗ドナーHLA抗体陽性の肝移植の短期・長期成績と問題点 抗ドナー抗体陽性生体肝移植の現状と問題点

    楳田 祐三, 八木 孝仁, 田中 健大, 吉田 龍一, 信岡 大輔, 杭瀬 崇, 吉田 一博, 安井 和也, 吉田 真里, 白川 靖博, 柳井 広行, 高木 章乃夫, 藤原 俊義

    移植   53 ( 総会臨時 )   257 - 257   2018.9

     More details

    Language:Japanese   Publisher:(一社)日本移植学会  

    researchmap

  • 抗ドナーHLA抗体陽性の肝移植の短期・長期成績と問題点 抗ドナー抗体陽性生体肝移植の現状と問題点

    楳田 祐三, 八木 孝仁, 田中 健大, 吉田 龍一, 信岡 大輔, 杭瀬 崇, 吉田 一博, 安井 和也, 吉田 真里, 白川 靖博, 柳井 広行, 高木 章乃夫, 藤原 俊義

    移植   53 ( 総会臨時 )   257 - 257   2018.9

     More details

    Language:Japanese   Publisher:(一社)日本移植学会  

    researchmap

  • 【肝】大腸癌多発肝転移に対する手術の工夫 大腸癌多発肝転移に対する治療戦略 遺伝子変異解析を踏まえた術前化学療法の適応選別

    楳田 祐三, 八木 孝仁, 吉田 龍一, 信岡 大輔, 杭瀬 崇, 吉田 一博, 安井 和也, 香川 俊輔, 白川 靖博, 藤原 俊義

    日本消化器外科学会総会   73回   72 - 72   2018.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 肝切除における血清アルブミン動態 アルブミン製剤至適投与に向けて臨床指標を再考する

    吉田 一博, 楳田 祐三, 吉田 龍一, 信岡 大輔, 杭瀬 崇, 安井 和也, 香川 俊輔, 白川 靖博, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   73回   914 - 914   2018.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 切除可能膵癌における早期再発予測因子の解析

    吉田 龍一, 楳田 祐三, 信岡 大輔, 杭瀬 崇, 吉田 一博, 安井 和也, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   73回   175 - 175   2018.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 肝切除における血清アルブミン動態 アルブミン製剤至適投与に向けて臨床指標を再考する

    吉田 一博, 楳田 祐三, 吉田 龍一, 信岡 大輔, 杭瀬 崇, 安井 和也, 香川 俊輔, 白川 靖博, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   73回   914 - 914   2018.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 【肝】大腸癌多発肝転移に対する手術の工夫 大腸癌多発肝転移に対する治療戦略 遺伝子変異解析を踏まえた術前化学療法の適応選別

    楳田 祐三, 八木 孝仁, 吉田 龍一, 信岡 大輔, 杭瀬 崇, 吉田 一博, 安井 和也, 香川 俊輔, 白川 靖博, 藤原 俊義

    日本消化器外科学会総会   73回   72 - 72   2018.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 切除可能膵癌における早期再発予測因子の解析

    吉田 龍一, 楳田 祐三, 信岡 大輔, 杭瀬 崇, 吉田 一博, 安井 和也, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   73回   175 - 175   2018.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 膵腫瘍におけるゲノム解析-病態解明と臨床的意義 包括的アプローチによる浸潤性膵管癌の非侵襲的診断技術の構築

    吉田 一博, 楳田 祐三, 吉田 龍一, 信岡 大輔, 杭瀬 崇, 藤 智和, 安井 和也, Goel Ajay, 八木 孝仁, 藤原 俊義

    膵臓   33 ( 3 )   360 - 360   2018.5

     More details

    Language:Japanese   Publisher:日本膵臓学会  

    researchmap

  • von Hippel-Lindau病に合併した膵NETの治療戦略

    信岡 大輔, 杭瀬 崇, 楳田 祐三, 吉田 龍一, 吉田 一博, 安井 和也, 小西 大輔, 岡林 弘樹, 八木 孝仁, 藤原 俊義

    膵臓   33 ( 3 )   659 - 659   2018.5

     More details

    Language:Japanese   Publisher:日本膵臓学会  

    researchmap

  • Gene expression profiles in BRAF V600E mutant colorectal cancer and association with SFRP2 methylation status

    Kazuya Yasui, Takeshi Nagasaka, Toshiaki Toshima, Takashi Kawai, Kunitoshi Shigeyasu, Yoshiko Mori, Junko Haraga, Keiichiro Nakamura, Yuzo Umeda, Hiroshi Tazawa, Ajay Goel, Toshiyoshi Fujiwara

    CANCER RESEARCH   77   2017.7

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:AMER ASSOC CANCER RESEARCH  

    DOI: 10.1158/1538-7445.AM2017-5711

    Web of Science

    researchmap

  • Clinicopathological significance of endometrial cancer with MSH2 deficiency

    Junko Haraga, Takeshi Nagasaka, Keiichirou Nakamura, Tomoko Haruma, Takeshi Nishida, Akihiro Nyuya, Kazuya Yasui, Hisashi Masuyama, Toshiyoshi Fujiwara, Yuji Hiramatsu

    CANCER RESEARCH   77   2017.7

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:AMER ASSOC CANCER RESEARCH  

    DOI: 10.1158/1538-7445.AM2017-4277

    Web of Science

    researchmap

  • Comprehensive analysis of intrahepatic cholangiocarcinoma based on viral infections and mutational status in the IDH1/2 and KRAS genes

    Kazuya Yasui, Takeshi Nagasaka, Yuzo Umeda, Tomokazu Fuji, Fumitaka Taniguchi, Toshiaki Toshima, Keisuke Kimura, Takashi Kawai, Yoshiko Mori, Hiroshi Tazawa, Takahito Yagi, Ajay Goel, Toshiyoshi Fujiwara

    CANCER RESEARCH   76   2016.7

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:AMER ASSOC CANCER RESEARCH  

    DOI: 10.1158/1538-7445.AM2016-3172

    Web of Science

    researchmap

  • A novel circulating cell free DNA-based assay in colorectal cancer patients during treatment with systematic chemotherapy

    Toshiaki Toshima, Takeshi Nagasaka, Yoshiko Mori, Takashi Kawai, Tomokazu Fuji, Fumitaka Taniguchi, Keisuke Kimura, Kazuya Yasui, Hiroyuki Kishimoto, Yuzo Umeda, Hiroshi Tazawa, Ajay Goel, Toshiyoshi Fujiwara

    CANCER RESEARCH   76   2016.7

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:AMER ASSOC CANCER RESEARCH  

    DOI: 10.1158/1538-7445.AM2016-510

    Web of Science

    researchmap

  • PD-1 and PD-L1 expression patterns and DNA mismatch repair status for precision management of patients with gastric cancer

    Keisuke Kimura, Takeshi Nagasaka, Yoshiko Mori, Takashi Kawai, Tomokazu Fuji, Fumitaka Taniguchi, Kazuya Yasui, Toshiaki Toshima, Yuzo Umeda, Hiroshi Tazawa, Ajay Goel, Toshiyoshi Fujiwara

    CANCER RESEARCH   76   2016.7

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:AMER ASSOC CANCER RESEARCH  

    DOI: 10.1158/1538-7445.AM2016-2317

    Web of Science

    researchmap

  • Micro RNAs as promising therapeutic targets for anti-metastatic therapy in colorectal cancer

    Takashi Kawai, Takeshi Nagasaka, Yoshiko Mori, Tomokazu Fuji, Fumitaka Taniguchi, Keisuke Kimura, Toshiaki Toshima, Kazuya Yasui, Yuzo Umeda, Hiroshi Tazawa, Ajay Goel, Toshiyoshi Fujiwara

    CANCER RESEARCH   76   2016.7

     More details

    Language:English   Publishing type:Research paper, summary (international conference)   Publisher:AMER ASSOC CANCER RESEARCH  

    DOI: 10.1158/1538-7445.AM2016-1078

    Web of Science

    researchmap

  • 結腸右半切除を伴う拡大膵頭十二指腸切除術後の再建の工夫

    佐藤 博紀, 信岡 大輔, 安井 和也, 高木 弘誠, 杭瀬 崇, 内海 方嗣, 吉田 龍一, 楳田 祐三, 篠浦 先, 八木 孝仁, 藤原 俊義

    日本消化器外科学会雑誌   48 ( Suppl.2 )   203 - 203   2015.10

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 腹腔鏡下肝切除の適応拡大に向けたcadaver trainingの実際

    信岡 大輔, 八木 孝仁, 近藤 喜太, 佐藤 博紀, 森廣 俊昭, 高木 弘誠, 安井 和也, 杭瀬 崇, 内海 方嗣, 吉田 龍一, 楳田 祐三, 篠浦 先, 大塚 愛二, 藤原 俊義

    日本消化器外科学会雑誌   48 ( Suppl.2 )   206 - 206   2015.10

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 世界へ発信する移植外科医療 生体肝移植の更なる発展を目指して 技術革新と手術戦略による移植予後の向上

    楳田 祐三, 八木 孝仁, 篠浦 先, 吉田 龍一, 信岡 大輔, 杭瀬 崇, 内海 正嗣, 高木 弘誠, 安井 和也, 藤原 俊義

    日本消化器外科学会総会   70回   SY - 6   2015.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 肝臓外科領域における手術手技の工夫 再肝切除における根治性確保と合併症軽減に向けた工夫

    安井 和也, 楳田 祐三, 篠浦 先, 吉田 龍一, 信岡 大輔, 内海 方嗣, 杭瀬 崇, 高木 弘誠, 八木 孝仁, 藤原 俊義

    日本消化器外科学会総会   70回   SY - 16   2015.7

     More details

    Language:Japanese   Publisher:(一社)日本消化器外科学会  

    researchmap

  • 難治性手術部位感染に対する局所陰圧閉鎖療法の工夫

    佐藤 博紀, 信岡 大輔, 近藤 喜太, 安井 和也, 高木 弘誠, 杭瀬 崇, 内海 方嗣, 吉田 龍一, 楳田 祐三, 篠浦 先, 八木 孝仁, 藤原 俊義

    日本肝胆膵外科学会・学術集会プログラム・抄録集   27回   666 - 666   2015.6

     More details

    Language:Japanese   Publisher:(一社)日本肝胆膵外科学会  

    researchmap

  • 迷わない確実な膵吻合術を目指して2 再使用可能なシリコンレプリカ膵臓を用いた膵管空腸吻合を用いた吻合トレーニングモデルの開発

    八木 孝仁, 篠浦 先, 楳田 祐三, 吉田 龍一, 信岡 大輔, 内海 方嗣, 高木 弘誠, 佐藤 博紀, 安井 和也, 藤原 俊義

    日本肝胆膵外科学会・学術集会プログラム・抄録集   27回   420 - 420   2015.6

     More details

    Language:Japanese   Publisher:(一社)日本肝胆膵外科学会  

    researchmap

  • 肝内胆管癌の治療方針 肝内胆管癌の外科治療 リンパ節郭清結果を踏まえ手術戦略を見直す

    楳田 祐三, 八木 孝仁, 篠浦 先, 吉田 龍一, 信岡 大輔, 佐藤 太祐, 杭瀬 崇, 高木 弘誠, 安井 和也, 藤原 俊義

    日本肝胆膵外科学会・学術集会プログラム・抄録集   27回   429 - 429   2015.6

     More details

    Language:Japanese   Publisher:(一社)日本肝胆膵外科学会  

    researchmap

  • 腹腔鏡下肝嚢胞開窓術のポイント

    信岡 大輔, 八木 孝仁, 森廣 俊昭, 佐藤 博紀, 安井 和也, 高木 弘誠, 杭瀬 崇, 内海 方嗣, 吉田 龍一, 楳田 祐三, 篠浦 先, 藤原 俊義

    日本肝胆膵外科学会・学術集会プログラム・抄録集   27回   507 - 507   2015.6

     More details

    Language:Japanese   Publisher:(一社)日本肝胆膵外科学会  

    researchmap

  • 腹腔鏡下肝嚢胞開窓術のピットフォール

    森廣 俊昭, 信岡 大輔, 佐藤 博紀, 安井 和也, 高木 弘誠, 杭瀬 崇, 内海 方嗣, 吉田 龍一, 楳田 祐三, 篠浦 先, 八木 孝仁, 藤原 俊義

    岡山医学会雑誌   127 ( 1 )   76 - 76   2015.4

     More details

    Language:Japanese   Publisher:岡山医学会  

    researchmap

  • PS-107-2 遠隔転移再発病巣に対する外科的切除適応におけるPET/CTの役割(PS-107 ポスターセッション(107)基礎-1,第111回日本外科学会定期学術集会)

    安井 和也, 片岡 正文, 岡田 剛, 安原 功, 國府島 健, 谷口 文崇, 前田 直見, 石川 亘, 須井 健太, 稲葉 基高, 児島 亨, 丸山 昌伸, 新田 泰樹, 木村 臣一, 高畑 隆臣, 仁熊 健文, 赤在 義浩, 西山 宜孝, 三村 哲重, 木村 秀幸, 大原 利憲

    日本外科学会雑誌   112 ( 1 )   689 - 689   2011.5

     More details

    Language:Japanese   Publisher:一般社団法人日本外科学会  

    CiNii Article

    CiNii Books

    researchmap

  • 縦隔におよぶ広範な気腫を呈したS状結腸捻転穿孔の1例

    丸山 昌伸, 岡田 剛, 安井 和也, 稲葉 基高, 三村 哲重

    日本腹部救急医学会雑誌   31 ( 2 )   428 - 428   2011.2

     More details

    Language:Japanese   Publisher:(一社)日本腹部救急医学会  

    researchmap

▼display all